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Background: Gestational Diabetes Mellitus (GDM) has been linked with later metabolic 
abnormalities in offspring due to subsequent overweight and obesity. In Sub-Saharan Africa, 
there is a paucity of data on the outcomes of children exposed to GDM in utero.  
Aims: The primary aim of this sub-study was to investigate the prevalence of overweight and 
obesity in 5 and 6-year-old children from GDM complicated pregnancies and macrosomia at 
birth in the same cohort. The secondary aim was to identify risk factors associated with 
overweight and obesity in these 5 and 6-year-old children.  
Outcome measures: The main outcome was the prevalence of overweight and obesity in 
these children as measured by their age-specific body mass index (BMI) and Z-scores. 
Additionally, the association between other risk factors, overweight and obesity was 
investigated.   
Methods: A cross-sectional sub-study design was employed nested within a larger study that 
is investigating the progression to type 2 diabetes in women managed for GDM during 2010 
and 2011. Mothers who participated in the larger study were informed about the sub-study and 
invited to allow their children to participate in the sub-study. Written informed consent was 
obtained from the mothers for the sub-study. The following data were collected: anthropometric 
data at birth and pregnancy related information from the mothers’ hospital record, additional 
demographic, social and medical information by questionnaire from the mother and at the 
research center. In addition, the children were weighed and had their height measured using 
standardized methods. Anthropometry was standardized using WHO standards. Risk factors 
for overweight and obesity were tested using a BMI>1 Z-score cut-off, (as a binary variable) in 
a manual multivariate logistic regression model. 
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Results: The sub-study recruited 176 participants; 78 boys (44.3%) and 98 girls (55.7%). The 
mean (SD) Z-scores for the children’s anthropometry at ages 5 to 6 years were 0.28 (1.40) for 
weight, 0.01 (1.07) for height and 0.37 (1.63) for BMI. The overall prevalence of macrosomia 
at birth (birth weight>4000 gm) was 12.3 % (95% CI 8.2-9.1). The overall prevalence of 
overweight in the 5 and 6-year-old children was 13.4% (95% CI 8.6-20.4), while the prevalence 
of obesity was 14.2% (95% CI 9.2-21.2). The combined prevalence of overweight and obesity 
was 27.6% (95% CI 20.6-35.9). The prevalence of macrosomia (P=0.53) or overweight/obesity 
proportions (P=0.37) at ages 5 to 6 years did not differ by gender. In multivariate logistic 
regression analysis, factors independently associated with the risk of overweight and obesity 
were: mothers’ oral glucose tolerance test 2-hour blood glucose level during pregnancy 
(AOR=2.06, 95% CI 1.14-3.74, P=0.02), birth weight (AOR=1.00, 95% CI 1.00-1.00, P=0.01), 
child’s age in years (AOR=0.03, 95% CI 0.002-0.29, P=0.004) and number of adults in the 
house (AOR=0.38, 95% CI 0.17-0.86, P=0.02).  
Conclusion: This is the first study to report the prevalence of overweight and obesity in 
children born from GDM complicated pregnancies, in the Western Cape, South Africa. The 
combined prevalence of overweight and obesity found in 5 and 6-year-old children exposed to 
GDM in the Western Cape is higher than overweight and obesity in children reported in other 
South African studies. This can imply a higher tendency towards overweight and obesity in 
children exposed to GDM which needs further exploration. 
Keywords: diabetes, gestational, childhood, fetal macrosomia, obesity, overweight, Z-score 





AGA – Appropriate for Gestational Age 
BMI - Body Mass Index 
CDC - Centers for Disease Control and Prevention 
GDM - Gestational Diabetes Mellitus  
GSH - Groote Schuur Hospital 
IGT - Impaired Glucose Tolerance 
IOTF- International Obesity Task Force 
JHNEBP - John Hopkins Nursing Evidence Based Practice  
LGA - Large for Gestational Age  
NCBI - National Center for Biotechnology Information  
NCPP - National Collaborative Perinatal Project 
NDDG - National Diabetes Data Group 
NGT- Normal Glucose Tolerance 
OGDM- Offspring’s of Gestational Diabetes Mothers 
ONDM - Offspring’s of Non-Diabetic Mothers 
OT1DM - Offspring’s of Type 1-Diabetic Mothers 
OGTT - Oral Glucose Tolerance Test 
SES - Socio-Economic Status 
SOP - Standard Operating Procedures  
T1DM - Type 1 Diabetes Mellitus 
T2DM - Type 2 Diabetes Mellitus 
UNICEF - United Nations Children's Fund 




Adolescent: This period of development corresponds roughly to the period between the 
ages of 10 and 19 years, which is consistent with the World Health Organization's definition 
of adolescence.  
Body Mass Index (BMI): a simple index of weight-for-height that is used to categorize 
overweight and obesity in adults. It is defined as a person's weight in kilograms divided by the 
square of his height in meters/kg/m² (WHO, 2015). 
Chronic medication: The term chronic applied when the course of a disease or diseases 
lasts for more than three months. Medication used to treat or manage these diseases, 
prescribed for three months or longer is referred to as “chronic medication”. 
Drinker: A person who uses alcohol in any form or amount  
Epigenetic alteration: A heritable change that does not affect the DNA sequence but results 
in a change in gene expression. 
Fetal Macrosomia: A condition that take place when the overgrowth of a fetal leads to a large-
for-gestational-age (LGA) fetus. According to the National Center for Biotechnology Information 
(NCBI), it is defined as birth weight over 4,000 grams or above the 90th percentile for population 
and gender-specific growth curves. Infant macrosomia is commonly seen in gestational 
diabetes, prolonged pregnancy and pregnancies complicated by pre-existing diabetes mellitus 
(NCBI, 1987). For purposes of this sub-study the term macrosomia is used and refers to fetal 
macrosomia. 
Gestational Diabetes Mellitus: is diabetes induced by pregnancy but resolved at the end of 
pregnancy. It does not include previously diagnosed diabetics who become pregnant 
(pregnancy in diabetics). Gestational diabetes usually develops in late pregnancy when insulin 
antagonistic hormones peak leading to insulin resistance; glucose intolerance; and 
hyperglycemia (NCBI, 1992). 
Less active: In this sub-study “less active” refers to people with physical activity/exercise of 
less than once a week. 
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Low income: In a South African context, it can be defined as Households who reported an 
annual household income of between R1 and R19 200. According to the Income and 
Expenditure Survey 2010/2011 (IES 2010/11), the average annual household income for poor 
households was R25 348. 
More active: In this sub-study “more active” refers to people with physical activity/exercise of 
more than twice a week. 
Obesity: Children were classified as obese if their weight-for-height exceeded the 95th 
percentile for population and gender-specific growth curves (Baptiste-Roberts, Nicholson, 
Wang & Brancati, 2012). Obesity in adults is defined as a BMI higher than 30 kg/m² (WHO, 
2015). 
Overweight: Children were classified as overweight if their weight-for-height exceeded the 
85th percentile for population and gender-specific growth curves (Baptiste-Roberts et al., 
2012). Overweight in adults is defined as a BMI higher than 25 kg/m² (WHO, 2015). 
LGA: Infants whose weight is > the 90th percentile for gestational age are classified as LGA.  
Macrosomia: is birth weight > 4000 g in a term infant. 
Standardized Z-scores: Z-score – The deviation of an individual’s value from the median 
value of a reference population, divided by the standard deviation of the reference population 
(WHO, 1997).  
Standardized Z-score classification: 
 Overweight = (1 <weight Z-score≤2) 
 obese = (>2 weight Z-scores) 
 thin = (<-2 weight Z-scores) 
 very thin = (<-3 weight Z-scores) 
 normal = (1<weight Z-score>2) 
Undernutrition:  A deficiency of proper nutrition, caused by not having sufficient food or not 
eating enough food containing substances necessary for growth and health. 
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WHO BMI cut-offs: The World Health Organisation (WHO) Global Database on Child Growth 
and Malnutrition uses a Z-score cut-off point of <-1 SD to classify low weight-for-age, low 
height-for-age and low weight-for-height as moderate and severe undernutrition, and <-2 SD 
to define severe undernutrition. The cut-off point of >+1 SD classifies high weight-for-height as 
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Chapter 1 INTRODUCTION 
1.1  Background 
Gestational Diabetes Mellitus (GDM), is associated with overweight and obesity in children and 
is usually diagnosed for the first time during pregnancy using an oral glucose tolerance test 
(Gilmartin, Ural and Repke, 2007). Worldwide, GDM is on the rise, while in Africa, there are 
scant data on the prevalence of GDM which varies between 0 and 14% (Macaulay, Dunger 
and Norris, 2014; Mwanri, Kinabo, Ramaiya and Feskens, 2015). In Sub-Saharan Africa, there 
is a paucity of data on the outcomes of children exposed to GDM in utero. In South Africa, 
GDM prevalence has been estimated to be as high as 26% (Adam & Rheeder, 2017). 
Childhood obesity is one of the most serious public health challenges of the 21st century 
(WHO, 2016). Globally, the increasing rate of childhood overweight and obesity poses 
significant public health problems from birth and, if these children remain overweight or obese, 
throughout their adult lives (Reilly & Kelly, 2011). Overweight and obese children are more 
likely to develop cardio-metabolic conditions such as type 2 diabetes mellitus (T2DM), 
cardiovascular conditions, and various cancers at a younger age compared to children who 
are of normal weight (Ge, Zhang, Schatten and Sun ( 2014) Swinburn et al., 2011). In Africa, 
there are no data on the cardio-metabolic outcomes (including overweight and obesity) of 
children exposed to GDM, despite the fact that GDM prevalence appears to be on the rise. 
Convincing evidence demonstrates notable increases in overweight and obesity in low- and 
middle-income countries (LMIC) (WHO, 2015).  In a systematic review of 144 countries, De 
Onis, Blössner and Borghi (2010) estimated that the prevalence of childhood overweight and 
obesity worldwide rose from 4.2% (95% CI: 3.2%, 5.2%) in 1990 to 6.7% (95% CI: 5.6%, 7.7%) 
in 2010. A systematic review by Ng et al., (2014) for the period 1980 to 2013 examined the 
global, regional and national prevalence of overweight and obesity in children and adults of 
188 countries using the international Obesity Task Force (IOTF) criteria. The prevalence of 
overweight and obesity increased from 29.8% to 38% for women and from 8.1% to 12.9% for 
children and adolescents worldwide and in developing countries, from 8.1% (7.7-8.6) to 12.9% 
(12.3-13.5) in 2013 for boys and from 8.4% (8.1-8.8) to 13.4% (13.0-13.9) in girls (Ng et al., 
2014). The number of overweight or obese children in Africa has nearly doubled from 5.4 million 
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to 10.3 million between 1990 and 2014 (WHO, 2016). Furthermore, of the overweight children 
under 5 years of age in 2014, 48% lived in Asia and 25% in Africa (WHO, 2016). 
Several studies have investigated the prevalence of overweight and its associated risk factors 
in children such as lack of physical activity and unhealthy dietary practices at home and at 
school (Mwaikambo, Leyna, Killewo, Simba, & Puoane, 2015) that can be improved through 
government policies (Swinburn et al., 2011).  
This study was a sub-study within a larger cross-sectional study which is investigating the 
prevalence of T2DM and associated risk factors in South Africa 5 years after gestational 
diabetes mellitus has been diagnosed. In the present sub-study, the aim was to investigate the 
prevalence of macrosomia at birth and the prevalence of overweight and obesity in the cohort 
of children of the women in the larger study, aged 5 to 6 years living in the Western Cape of 
South Africa, exposed to GDM during pregnancy. 
1.2 Problem Statement 
A review of published national and international studies has identified childhood obesity as a 
growing public health epidemic that affects children’s physical and mental health (WHO, 2014) 
and if continued into adulthood, results in chronic illness. Despite recent published data on 
childhood overweight and/or obesity in South Africa, studies do not appear to have addressed 
this phenomenon in children exposed to GDM during pregnancy, despite the reported high 
GDM prevalence. This sub-study has attempted to address this gap in knowledge (Burns & 
Grove, 2011).  
1.3 Research Questions 
This sub-study investigated three questions:  
1. What is the prevalence of overweight at birth of infants delivered at the Groote Schuur 
hospital during November 2010 and November 2011 who were exposed to GDM during 
the pregnancy? 
2. What is the prevalence of overweight and obesity in the same cohort of 5 and 6-year-
old children as assessed in 2016-2017?  




1.4 Aims and Objectives of the sub-study 
1.4.1 Aims 
The primary aim of the sub-study was to investigate the prevalence of macrosomia at birth from 
GDM complicated pregnancies in the Western Cape, South Africa and overweight and obesity 
in the same cohort of 5 and 6-year-old children. The secondary aim was to identify the risk 
factors associated with overweight and obesity in these 5 and 6-year-old children born from 
GDM complicated pregnancies.  
1.4.2 Objectives 
To achieve the above aim, the sub-study addressed the following objectives: 
1.4.2.1 To describe the anthropometric characteristics of the infants exposed to GDM during 
pregnancy in the years 2010 and 2011 at Groote Schuur Hospital (GSH) and in the 
same cohort of 5 and 6-year-old children. 
1.4.2.2 To determine the proportion of macrosomia in the same cohort. 
1.4.2.3 To estimate the prevalence of overweight and obesity in the same cohort of 5 and 6-
year-old children by calculating the proportion of overweight and obese children using 
WHO BMI cut-offs as well as standardized Z-scores. 
1.4.2.4 To identify factors (child and maternal) associated with increased risk for overweight 
and obesity in these 5 and 6-year-old children exposed to GDM during pregnancy. 
1.4.2.5 To compare the anthropometric measures and the prevalence of overweight and 




1.5 Rationale for the sub-study 
Apart from describing the prevalence of macrosomia in GDM offspring at birth within a local 
Western Cape context, this sub-study provides the only data on the prevalence of overweight 
and obesity in children from GDM complicated pregnancies and factors extraneous to GDM 
that may increase the risk of overweight and obesity in 5 and 6-year-old children. Identification 
of these risk factors will help in designing appropriate, context-specific strategies to prevent or 
counter overweight and obesity in 5 and 6-year-old children. 
1.6 Summary 
A global increase in childhood overweight and obesity and in GDM, particularly in low- and 
middle-income countries, with evidence suggesting that preschool children exposed to GDM 
may have a higher risk for overweight and obesity than non-GDM exposed children is of 
concern. The paucity of published literature from Africa on macrosomia in GDM exposed 
newborns as well as overweight and obesity prevalence in 5-6 year olds and the associated 
risk factors contributing to childhood overweight also encouraged research in these areas. The 
aim of this sub-study was to investigate the prevalence of overweight and obesity in GDM-
exposed 5 and 6-year-old children. The following chapter deals with a review of the pertinent 




Chapter 2 LITERATURE REVIEW 
2.1 Introduction 
This chapter provides a review of the literature that was used to guide the development of the 
sub-study and research instruments and for interpreting the results. The review is a critique of 
existing research on the prevalence of overweight and obesity in preschool children exposed 
to GDM and informs the study on appropriate study methods as well as gaps in the literature 
(Burns & Grove, 2011) where further research is required.  
Researchers have documented a vast amount of literature and have concluded that childhood 
overweight and obesity develops into adult overweight or obesity and can cause serious 
metabolic conditions and cardiac diseases. A review of the literature addressed the three 
research questions in this sub-study.  
1) What is the prevalence of overweight at birth of infants (macrosomia) exposed to GDM 
during a pregnancy? 
2) What is the prevalence of overweight and obesity in 5 and 6-year-old children exposed to 
GDM?  
3) What are the risk factors associated with overweight and obesity in these children? 
2.2 Literature search strategy 
The search strategy employed for the sub-study identified studies that focused on the 
prevalence of overweight and obesity in 5 and 6-year-old children from GDM complicated 
pregnancies and associated risk factors. The searched dates primarily ranged from 2005 to 
2016. The earliest reference (1987) is for a NCBI MESH search. Other relevant but dated 
sources were included. 
The following search filters were used: journal articles, English language, free full text, human, 
and age limits (infant: birth-23 months, preschool child: 2 to 5 years, child: 6 to 12 years). A 
detailed and wide search strategy was developed using the following electronic databases: 
PubMed, Medical Subject Headings (MeSH), Africa-wide Information via EBSCOhost, 
ScienceDirect, Google Scholar, EBSCOhost and the Cochrane Library. The Boolean operators 
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‘AND’ and ‘OR’ were used as studies combining childhood overweight associated with GDM 
were limited. The search terms (keywords) gestational diabetes, fetal macrosomia, Africa, 
South Africa, Western Cape, childhood overweight, childhood obesity, childhood Z-score and 
risk factors were used in various combinations.  
Searched articles were limited to the English language and human subjects. Studies that did 
not report or allow computational data of the prevalence of overweight and obesity in 5 and 6-
year-old children from GDM complicated pregnancies and associated risk factors were 
excluded. The term GDM alone resulted in 6 articles while other keywords such as ‘fetal 
macrosomia’, ‘fetal macrosomia and overweight’, ‘fetal macrosomia and obesity were 
unsuccessful. The terms ‘GDM and pregnancy’ resulted in 8 articles while the term ‘GDM and 
fetal macrosomia’ was unsuccessful. The term ‘fetal macrosomia or obesity’ resulted in 130 
hits. Combining terms ‘fetal macrosomia or childhood overweight or childhood obesity or risk 
factors or childhood Z-scores’ resulted in 6,468 articles. The most successful search resulted 
in 3,327 published papers. Lastly South Africa, Western Cape, Z-score and risk factors were 
used in different combinations to focus the search.  
Search results showed that the published research on children exposed to GDM in utero is 
limited. Research specific to Africa, South Africa and the Western Cape is even more limited 
in scope and availability. Reference lists were hand searched for relevant articles, books, and 
grey literature.. The refined search strategy resulted in a total of 155 articles. This resulted in 
54 references that were reviewed and met the study’s criteria for inclusion. Eighty-six studies 
were excluded because data could not be extracted from the articles to determine the 
prevalence of overweight and obesity in 5 and 6-year-old children from GDM complicated 
pregnancies and associated risk factors. Upon closer inspection, another 15 references were 
excluded because the articles were either ambiguous, dated or did not meet inclusion criteria. 
















Figure 2.1: Flow diagram of the literature search process 
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2.3 Assessment of hierarchy of evidence of the reviewed studies 
The reviewed studies on GDM and the prevalence of overweight and obesity in preschool 
children were evaluated by hierarchy of evidence as shown in Figure 2.2. 
 
 
Figure 2. 2: Hierarchy of evidence of the reviewed studies 
(Reference: http://3.bp.blogspot.com/-VCmwq8LFAk4/T1-UId5KcGI/AAAAAAAAAog/foLHY 
3nWBUs/s1600/1.gif) 
Systematic reviews at the top of the pyramid are considered to provide the highest levels of 
evidence, whereas editorials and expert opinion are at the base of the triangle. The study 
design of the reviewed studies is shown in Table 2.2. 
2.4 Assessment of the quality of the reviewed studies 
The quality of the reviewed studies regarding GDM exposure and preschool overweight and 
obesity has been rated according to the Johns Hopkins Nursing Evidence-Based Practice 
(JHNEBP) Appraisal Tool (Newhouse, Dearholt, Poe, Pugh & White, 2005; Appendix F) as A 
(high quality), B (good quality) and C (low quality or major flaws (Table 2.1). 
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Table 2.1: Johns Hopkins Nursing Evidence-Based Practice Appraisal Tool (John 
Hopkins Medicine, 2005) 
A: High quality: consistent, generalizable results; sufficient sample size for the study 
design; adequate control; definitive conclusions; consistent 
recommendations based on comprehensive literature review that 
includes thorough reference to scientific evidence 
B: Good quality: reasonably consistent results; sufficient sample size for the study 
design; some control, and fairly definitive conclusions; reasonably 
consistent recommendations based on fairly comprehensive literature 
review that includes some reference to scientific evidence 
C: Low quality or 
major flaws: 
little evidence with inconsistent results; insufficient sample size for the 
study design; conclusions cannot be drawn 
 
2.5 Introduction and themes extracted from a review of the published literature 
Overweight and obesity are defined as excessive fat growth that presents a risk to a person’s 
health (WHO, 2015). Weight that is higher than that considered as healthy for a given height is 
described as overweight or obese (CDC, 2016). Body Mass Index (BMI), is used as a screening 
tool for overweight or obesity in adults. In children BMI is age-and gender-specific and is often 
referred to as BMI-for-age (CDC, 2016). The WHO has different criteria for identification of 
overweight and obesity in adults and children.  
Overweight and obesity BMI cut-offs are not a good indication of overweight as overweight can 
develop before these cut-off points are reached (WHO, 2016).  For example, children can 
develop more abdominal fat even if their BMI is within normal limits (WHO 2016). For this sub-
study, 5 and 6-year-old participants’ weight-for-age Z-scores were compared with the WHO 
Child Growth Standards to determine if they were overweight or obese. Overweight in children 
is described as weight-for-height Z-score values with more than 2 standard deviations based 
on the WHO growth standard median for age and gender (WHO, 2016).  Obesity in children is 
described as children with weight-for-height Z-scores values 3 times above standard deviations 




The following themes related to the study focus were extracted: 
 GDM, fetal macrosomia and prevalence (research question 1) 
o Background to GDM and fetal macrosomia 
o Prevalence of fetal macrosomia in GDM exposed infants 
 Overweight and obesity in children and overweight and obesity in children exposed to 
GDM (research question 2) 
o Prevalence of overweight and obesity in children 
 Risk factors associated with overweight and obesity in children (research question 3)  
o Health risks in overweight and obesity in children and burden on health services 
o Interventions needed for overweight and obesity in children 
A discussion of each theme follows and a summary of the themes and the literature is 
presented in Table 2.2. 
2.5.1 GDM, fetal macrosomia and prevalence 
2.5.1.1 Background to GDM related to fetal macrosomia and childhood overweight 
Diabetes Mellitus is defined as a chronic disease when the body does not make sufficient 
quantities of the hormone insulin, or when the body cannot efficiently use the insulin it makes 
(WHO, 2016) to control blood sugar levels. Raised blood sugar levels pose serious health 
threats and risks to a person with uncontrolled diabetes. The three sub-categories of Diabetes 
Mellitus: Type 1 (T1DM), Type 2 (T2DM) and Gestational Diabetes Mellitus are described 
below: 
 T1DM: (insulin-dependent diabetes) a condition where the body cannot produce 
sufficient insulin to control normal blood sugar levels.  
 T2DM: (previously named non-insulin dependent or adult-onset diabetes) is caused by 
the body’s improper use of insulin and usually develops in adulthood (WHO, 2016) and 
seen mostly in adults, but worldwide, since the mid-1990s is occurring more often in 
children (WHO, 2016; Reinehr, 2013). 
 GDM: any degree of glucose intolerance with onset or first recognition during pregnancy  
(Metzger, Coustan, & Committee, 1998) and diagnosed by using the WHO (2014) 
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criteria based on a 2-hr 75g Oral Glucose Tolerance Test. Cut offs: for Fasting Blood 
glucose between 5.1 and 6.9 mmol/L; 1-hr plasma glucose ≥10.0 mmol/L (180mg/dL) 
and a 2-hr plasma glucose result of 8.5-11.0 mmol/L (153-199 mg/dL) (WHO, 2016).  
Why may GDM, a state of glucose intolerance during pregnancy, pose a risk and lead to 
overweight in children and later in their adult life? A healthy uterine environment is a basis for 
the normal development of the foetus and child in later life. In GDM the foetus can be exposed 
to high maternal blood sugar levels that create an imbalance in the uterine environment (Desai, 
Beall & Ross, 2012). In the Global Diabetes Report (2016), the WHO described high blood 
sugar in GDM as blood sugars above the normal value, but still below diagnostic values for 
diabetes (WHO, 2016). GDM has been linked to overweight at birth (fetal macrosomia) in 
exposed infants by many researchers.  
GDM is a commonly expected risk factor associated with infants who are large for gestational 
age (LGA) also known as fetal macrosomia. Fetal macrosomia is defined as a birth weight 
above 4,000 grams (Najafian & Cheraghi, 2012). Boney et al., (2005) found that children who 
were LGA, that is, having a birth weight above the 90th percentile, had been exposed to an 
intrauterine environment of either high blood sugar levels during uncontrolled diabetes or 
maternal obesity. A cohort study conducted in Iran showed that diabetes and maternal obesity 
(an increased BMI) were a major risk factor associated with macrosomia (Najafian & Cheraghi, 
2012).  Hyperglycemia in utero can cause epigenetic alterations which may subsequently 
cause overweight and obesity in mothers and their offspring later in life (Ruchat et al 2013). 
The mechanism through which GDM leads to both macrosomia and, possibly later childhood 
overweight and obesity is not clearly understood. However, intrauterine hyperglycemia during 
GDM may cause fetal hypothalamic changes that lead to leptin resistance (Vrachnis et al., 
2012). Data from studies demonstrated that placentas from mothers with GDM had altered 
DNA methylation patterns within their leptin and adiponectin genes (Ruchat et al., 2013). Cord 
blood leptin levels from GDM mothers were 29.3 ng/ml compared to 7.9 ng/ml in a control 
group (Dabelea, 2007). This increase in fetal leptin levels resulted in hyperinsulinemia and 
leptin resistance which is a forerunner of childhood obesity (Dabelea, 2007; Wright et al., 2009).  
Leptin resistance is postulated to be the origin of fetal epigenetics programming that causes 
obesity and results in metabolic conditions in childhood and later adult life (Vickers, 2007; Desai 
et al., 2012). The primary function of leptin is to inform the hypothalamus that one is satiated. 
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As a result of leptin resistance, there is increased fat accumulation in newborns which leads to 
hyperglycemia and high insulin levels (Desai et al., 2012). During the past decade, the world 
has witnessed a significant increase (25%) in high birth weight in babies associated with GDM 
(Desai et al., 2012). These high birth weight babies may have increased health risk factors 
such as adipose tissue mass and higher rates of obesity and diabetes in later life. 
2.5.1.2  Prevalence of fetal macrosomia in GDM exposed infants 
Few studies in Africa have investigated the prevalence of GDM as evidenced in two systematic 
reviews. In the first by Macaulay, Dunger and Norris (2014), data were available from 6 of 54 
(11%) African countries. The diversity of population groups and different diagnostic tests used 
to diagnose GDM indicates the difficulty in determining the prevalence of GDM in African 
countries and in interpreting data for the South African context. A systematic review by Mwanri 
et al., (2015) on the prevalence of and risk factors for GDM in 47 sub-Saharan African countries 
reports a prevalence of 14%. The results indicate a need for earlier screening for GDM and 
intervention to slow the progression of this disease and its complications in Sub-Saharan Africa 
(Mwanri et al., 2015). An Iranian cohort study reported that diabetic participants delivered a 
statistically significant number of macrocosmic babies (39.5%, P<0.05) compared to 6.1% in 
the control-group (Najafian et al., 2012). In Soweto, South Africa, findings from a recent 
unpublished pilot study (2016) have shown a GDM prevalence of 15%. However, there is 
limited published data from South Africa and the Western Cape on prevalence of GDM, risk 
factors associated with developing GDM and the outcomes of GDM on the exposed children. 
In some developed countries the prevalence of GDM ranged from 2% (Sweden) to 12.8% 
(Northern California) (Hunt & Schuller, 2007). In China, between 1999 and 2008 the prevalence 
of GDM increased from 2.4% to 6.8% (Zhang et al., 2011). Chinese children exposed to GDM 
in utero had a macrosomia prevalence of 14.0% versus 10.4% in infants not exposed to GDM 
(Zhao et al., 2015). An increased prevalence of 29% in LGA offspring of GDM (OGDM) mothers 
in the USA is reported by Boney et al., (2005). Wright et al., (2009) noted a Z-score of 0.26 
(0.92) in GDM exposed infants versus 0.18 (0.96) in offspring of NonGDM (ONGDM) mothers. 
A prevalence of 18% of LGA infants was found when mothers had a fasting glucose of >95 
mg/dl versus 8–9% in both treatment groups with a fasting OGTT≤ 95 mg/dl (Hillier et al., 2007). 
The Gillman, Rifas-Shiman, Berkey, Field & Colditz, (2003) study that investigated overweight 
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and obesity in GDM exposed children, concluded that infants of GDM mothers had higher 
birthweights than those of Non-GDM mothers. 
Prospective analysis of data from 28,358 USA mothers and their children enrolled in the 
National Collaborative Perinatal Project from 1959-1965 to determine the effects of GDM on 
growth patterns of their offspring from birth until age 7, showed that 1.7% of women had GDM 
(Baptiste-Roberts et al., 2012). Their children had both a higher average birth weight and a 
61% greater chance of being medically overweight upon reaching the age of 7 years. A Polish 
study documented a macrosomia prevalence of 20.6% In OGDM mothers versus 13% in 
ONGDM mothers (Wroblewska‐Seniuk, Wender‐Ozegowska & Szczapa, 2009).  
2.5.2 Overweight and obesity in children and overweight and obesity children (5-
6years old) exposed to GDM 
There is limited published research on the prevalence of overweight and obesity in children 
who had been exposed to GDM. Kim, England, Sharma and Njoroge (2011) were the first to 
complete a systematic review to investigate the prevalence of overweight and obesity in 
children exposed to GDM. In a USA study Kim et al., (2011) reported that the prevalence of 
overweight and obesity in GDM-exposed children was not statistically significant after 
adjustment for pre-pregnancy BMI (Table 2.2.  
A USA cohort study by Gillman et al., (2003) examined the association between birth weight 
and GDM and adolescent body mass index (BMI) and differentiated between GDM-specific 
effects and those caused mainly by maternal obesity. A sample of 7,981 girls and 6,900 boys 
between the ages of 9 and 14 (mean, 11.9 years) showed an increased risk of overweight for 
children exposed to GDM. The results estimated a 17.1% risk of being overweight and 9.7% 
were overweight in the GDM exposed children. In the group without GDM, 14.2% were at risk 
of being overweight and 6.6% were overweight. One major limitation of the Gillman study was 
recruitment of a study population of 93.6% white participants, which was not reflective of the 
general population. The strength of the study mainly involved the exclusion of pre-gestational 
diabetic mothers (Gillman et al., 2003) (Table 2.2). 
In another study conducted in the USA, Hillier et al., (2007) examined the prevalence of 
overweight and obesity in 5 to 7-year-old children exposed to GDM or untreated hyperglycemia 
compared to overweight and obesity in children with the same ages in non-diabetic mothers. 
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The risk of obesity in the children whose mothers had an increased fasting glucose of at least 
5.3 mmol/l (95 mg/dl) on the Oral Glucose Tolerance Test (OGTT) was nearly double that of 
the children whose mothers had a normal fasting blood glucose (p<0.0001) (Hillier et al., 2007). 
These study results emphasized the fact that it is not GDM per se, but whether the GDM was 
treated or not, that increased the risk of overweight or obesity in childhood (Hillier et al., 2007). 
The strengths of this cohort study were the diverse, large multi-ethnic population and that pre-
gestational diabetic mothers had been excluded. The reduction in sample size when some 
participants resigned from the Kaiser Permanente Medical insurance was documented as a 
limitation (Hillier et al., 2007).  
Results of the cohort study by Baptiste-Roberts et al., (2012) showed that prevalence of 
overweight in GDM exposed children was higher at 23.3% than 12.6% in non-GDM exposed 
children. This study included a large diverse population over a 7-year period but had several 
limitations which included: error in the assessment of gestational age, inability to adjust for 
unmeasured confounders, possible misclassification of GDM and limited generalizability since 
participants in the National Collaborative Perinatal Project had been enrolled more than 40 
years ago previously (Baptiste-Roberts et al., 2012).  
Studies from other countries were also compared with USA studies which dominated this 
research field. In a German cohort study, researchers investigated the prevalence of 
overweight and insulin resistance in children aged 2, 8 and 11 years exposed to GDM 
(Boerschmann, Pflüger, Henneberger, Ziegler & Hummel, 2010). Differences in prevalence of 
overweight in GDM exposed children compared to overweight in children of T1DM mothers 
and children of NDM were significant. In children exposed to GDM overweight prevalence 
was17.2% at age 2, 20.2% at age 8 and 31.1% at age 11 years; higher compared to 15.8%, 
11.0%, and15.8% in children of T1DM mothers and 11.4%, 10.3% and 15.5% in children of 
NDM mothers (Boerschmann et al., 2010). The P values were 0.006 at 2 years, 0.02 at 8 years 
and 0.01 at 11 years (Table 2.2). The strength of the Boerschmanns’ study was that the groups 
of participants involved were recruited over the same period and were from the same region 
and ethnicity. This could also be a limitation as study results could not be generalized to the 
broader population. In contrast, the study was limited because it did not investigate other 
common risk factors of childhood overweight, such as diet habits during that period in the 
child’s life, physical activity and socioeconomic status (Boerschmann et al., 2010). 
15 
 
In a Polish study, overweight and obesity in children 4 to 9 years old showed no statistically 
significant differences in BMI (Table 2.2) (Wroblewska-Seniuk et al., 2009). Similarly, a Korean 
study conducted by Lee, Jang, Park and Cho (2007)  concluded that 3 to 4-year-old children 
exposed to GDM during pregnancy had no significant increase in their BMI when compared to 
a control group (Lee et al., 2007). In comparison, the BMI of offspring of GDM mothers, who 
were 5 years old or more remained significantly higher (P<0.01) than that of offspring of IGT 
mothers (Lee et al., 2007).  
The results in these studies were not conclusive and could be due to several factors: the use 
of different glucose loads for the OGTT, the cut off results for OGTT to diagnose GDM not 
being the same, uncertainty of gestational age when GDM was diagnosed, the criteria to define 
overweight/obesity in studies were not the same in all studies and inconsistent investigation of 
additional risk factors. 
2.5.2.1 Prevalence of overweight and obesity in children 
 According to the Centers for Disease Control and Prevention (CDC), BMI is a ratio used to 
determine childhood overweight and obesity. For children, BMI is age and gender-specific and 
is often referred to as BMI-for-age. A child's weight status is determined using an age and 
gender-specific percentile for BMI because children's body compositions vary as they age. 
Therefore, BMI levels among children are expressed relative to other children of the same age 
and gender (CDC, 2016). Overweight is defined as a BMI at or above the 85th percentile and 
below the 95th percentile for children of the same age and gender (CDC, 2016). Obesity is 
defined as a BMI at or above the 95th percentile for children and teens of the same age and 
gender (CDC, 2016). 
2.5.2.2  Global Prevalence of overweight and obesity in children 
The WHO (2014) predicted an increase in childhood overweight in all regions worldwide from 
7% in 2012 to 11% in 2025. In 2013, the United Nations Children Fund (UNICEF), WHO and 
the World Bank estimated that the number of overweight and obese children younger than 5-
years old was expected to increase from 32 to 42 million in 3 years from 2000 to 2013 (World 
Health Organization, 2014). The 2014 Report of the Commission on Ending Childhood obesity 
indicated that 41 million children under the age of 5 were either overweight or obese (WHO, 
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2016). The highest number of overweight and obese children were reportedly in Africa (11 
million) and Asia (18 million) (World Health Organization, 2014).  
In the United States of America (USA), a representative National Health and Nutrition 
Examination Survey from 2011-2012 identified the obesity rate in children 2 to 5-years old as 
8.4% (Ogden, Carroll, Kit, & Flegal, 2014). A 2005 Canadian survey showed that 32.9% of 
grade 5 students aged 10 in Nova Scotia were overweight and 9.9% were obese (Veugelers & 
Fitzgerald, 2005). In India the prevalence of obesity between 1976 and 1980 in preschool 
children of both genders between the age of 2 and 5-years increased by 5% while in boys and 
girls between the age of 6 and 11 years the increase was 13.1% (Karnik & Kanekar, 2015).  
2.5.2.3 Prevalence of overweight and obesity in children in Africa 
The prevalence of childhood overweight and obesity in boys in developing countries increased 
from 8.1% in 1980 to 12.9% in 2013 and for girls from 8.45% to 13.4% as reported by Ng et 
al., 2014. Athough this was a large study, there were limitations. One very important limitation 
is that the study included surveys of self-reported weights and heights which resulted in 
systematic bias. Secondly, some studies were excluded because they did not include national 
figures (Ng et al., 2014). These authors concluded that obesity had increased over three 
decades with no national intervention success stories (Ng et al., 2014).  
Several African studies have shown a growing epidemic of overweight and obesity among 
children of different age groups. A cross-sectional study conducted in 26 of 49 countries in 
Sub-Saharan Africa from 2010 to 2014 reported that overweight and obesity in preschool 
children from birth to 59 months was estimated at 6.8% (Gebremedhin, 2015) increasingly 
becoming a public health risk with harmful health risks for adults (Gebremedhin, 2015).  
A cross-sectional study conducted in Kenya that included 320 children aged 3 to 6-years old, 
in public and private schools investigated the prevalence of overweight and obesity and 
associated risk factors. Childhood overweight and obesity were defined in terms of body mass 
index Z-scores. This study showed a prevalence of 13.4 % overweight and 6.9 % obesity 
(Wandia, Ettyang, & Mbagaya, 2014). A cross-sectional study conducted in Tanzania that 
included 1,722 children from public and private schools aged 7 to14 years, reported a 
prevalence of obesity of 10.2% and of overweight of 4.5% (Mwaikambo, Leyna, Killewo, Simba 
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& Puoane, 2015). A 2011 Demographic Health Survey of 2,205 boys and 2,313 girls in 
Cameroon (Central Africa), (mean age 30.2 months) conducted over a period of eight months 
reported BMI Z-scores based on the WHO 2006 reference showing a prevalence of 8% for 
overweight and obesity and 1.7% for obesity alone (Tchoubi et al., 2015).  
2.5.2.4  Prevalence of overweight and obesity in children in South Africa 
In South Africa, obesity rates among children and adolescents have reached epidemic 
proportions, with an estimated 1 out of every 5 children suffering from obesity (Van der Merwe, 
2012). Recent comparisons of prevalence studies in different regions in South Africa showed 
a mean prevalence of overweight and obesity of 15% (Rossouw, Grant, & Viljoen, 2012). 
Somers (2004), reported overweight and obesity prevalence rates among children aged 10 to 
16-years old, in the Western Cape and South Africa in general of 8.31% for overweight and 
2.97% for obesity  
A cross-sectional study conducted by Kruger et al., (2005), showed an overweight and obesity 
rate of 7.8% in 10 to 15-year old children in the North West province of South Africa. In 
Mpumalanga, South Africa, a cross-sectional growth survey of 3,511 children and adolescents 
aged between 1 and 20 years, investigated stunting, overweight and obesity, and metabolic 
disease risk (Kimani-Murage et al., 2010). For children aged 1 to 5 years, the 2006 WHO 
Growth Z-scores were used for the estimation; for those older than 6 years the 1977 
NCHS/WHO reference was used. The study found a prevalence of overweight and obesity of 
less than 5% among boys and girls aged 5 to 6 years. Irrespective of the different age groups 
and criteria used, most studies showed an increase in prevalence of childhood overweight and 
obesity. 
2.5.3 Risk factors associated with overweight and obesity in children 
Risk factors associated with childhood overweight and obesity was found to be similar in other 
published literature. A South African study found that low maternal education and sedentary 
lifestyle were risk factors that contributed to overweight and obesity in children aged 1 to 9 
years (Kruger et al., 2005).  
Maternal overweight/obesity itself is a known high-risk factor for development of GDM.  A 
maternal obesity study conducted by Chu and others (2007) showed that overweight pregnant 
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women had twice the risk while obese pregnant women had four times the risk for developing 
GDM as compared with normal-weight pregnant women (Chu et al., 2007). Maternal 
overweight and high birth weight were also found to be high risk factors for developing 
childhood overweight and/or obesity in other studies (Gebremedhin, 2015; Tchoubi et al., 
2015). Exposure to a hyperglycemic intrauterine environment was found to be a risk factor for 
association with greater adiposity from infancy (Barouki, Gluckman, Grandjean, Hanson, & 
Heindel, 2012). Desai et al., (2012) suggested that overweight and obesity in children are 
directly related to exposure to GDM in utero. However, a few limitations of the study were ages 
of the children were not mentioned and the significance of maternal obesity versus GDM as a 
leading cause for childhood overweight could not be distinguished. 
Risk factors associated with developing GDM include: increased age, smoking, family history 
of diabetes, obesity, history of previous GDM, history of macrosomia, stillbirth or birth to infant 
with congenital anomalies (WHO 2016; Gilmartin et al. 2007). The risk for developing GDM is 
higher in women aged 25 years and older and who are obese (Mamabolo, Alberts, Levitt, 
Delemarre-van de Waal & Steyn, 2007). Chu et al., (2007) also found that the risk to develop 
GDM is 2-8 times higher in overweight and obese women compared to normal weight pregnant 
women. These results were from a meta-analysis that investigated maternal obesity as risk for 
GDM in different countries including the USA, United Kingdom (UK), Italy, Canada and 
Australia (Chu et al., 2007).  
In a Kenyan prevalence study of childhood overweight and obesity, a higher prevalence of 
overweight and obesity was reported in private schools, compared to public schools (p<0.001) 
(Wandia et al., 2014).  The same study results showed that children of families that owned a 
television were more overweight or obese compared to those children from families that did 
not have television (p<0.002) (Wandia et al., 2014).  In India, risk factors associated with the 
increasing prevalence of childhood overweight and obesity were identified as the imbalance 
between energy consumed and energy used (Karnik & Kanekar, 2015). These risk factors can 
be grouped as behavioral such as watching television while snacking unhealthy foods and 
environmental factors such as safe side walks, that lead to reduced physical activity (Karnik & 
Kanekar, 2015).  
A Health of the Nation Study was used to determine prevalence of overweight and obesity in a 
cohort (2001 to 2004) of 10,195 South African primary school children aged 6 to 13 years. The 
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study showed that gender and ethnicity were the two main factors associated with obesity and 
overweight. The prevalence of obesity among boys was 2.4% and the prevalence of overweight 
was 4.8%. Using the method of Cole et al., (2000) to determine cut-off points for overweight 
and obesity, the prevalence of obesity in girls was 10.9% and 17.5% for overweight (Armstrong, 
Lambert, Sharwood & Lambert, 2006). A significant difference was demonstrated in overweight 
and obesity prevalence in black and white girls at ages 6 and 11 years. The percentage of 
overweight and obesity among black girls increased from 11.95% in 6-year olds to 21.8% in 
11-year old girls. Among white girls the prevalence of overweight and obesity was 25.4% for 
6-year olds and 14.5% for 11-year olds (Armstrong et al., 2006). 
A summary of study designs on prevalence of overweight and obesity in children, macrosomia 
in GDM exposed newborns versus newborns of Non-GDM mothers, additional risk factors 
associated with overweight and obesity and quality of evidenceis presented in Table 2.2. 
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Table 2.2: Summary of study designs on prevalence of overweight and obesity in children,macrosomia in GDM exposed 
newborns versus newborns of Non-GDM mothers, additional risk factors associated with overweight and obesity and quality 
of evidence 
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1 Offspring of Gestational Diabetes Mellitus (GDM) mothers (OGDM) 
2 Offspring of Non-GDM mothers (ONGDM) 
3 BMI growth curves for Chinese children and adolescents at 0–18 years of age, overweight in boys was defined as BMI⩾82nd 
percentile for age, and obesity was BMI⩾96.3 percentile for age, while in girls’ overweight was BMI⩾87.4 percentile for age and obesity 
was a BMI⩾98th percentile for age. 
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Studies in Table 2.2 show one systematic review (Fig 2.2), one observational study, five 
prospective cohort studies, one longitudinal cohort and one retrospective cohort study and the 
quality of evidence for all is rated an A (high). Surprisingly, there were no cross-sectional 
studies. Cohort studies are nevertheless also appropriate for descriptions of prevalence of 
overweight and obesity in children, macrosomia in GDM exposed and non-GDM exposed 
newborns and risk factors associated with overweight and obesity.  
2.5.3.1 Health risks in overweight and obesity in children and burden on health services 
The correct management of GDM is crucial to prevent possible maternal and infant 
complications which include overweight, obesity and metabolic conditions (Reece, Leguizamón 
& Wiznitzer, 2009). Obesity may lead to insulin-resistant metabolic conditions in affected 
children as they get older (Ge et al., 2014).  
Rossouw et al., (2012) reported that overweight and obesity were the main cause of 
psychological problems and low self-esteem during childhood and these children have difficulty 
interacting with others and fitting in with the rest of society (WHO, 2015; WHO, 2016). Low self-
esteem, depression and social isolation caused by overweight and obesity in children reduce 
confidence to participate in physical activities on school grounds or other areas. The global 
health problem of an increasing number of overweight and obese children is a burden on 
government resources and health care systems particularly in low-income countries but 
increasingly in middle-income countries such as South Africa. 
Overweight at age 4 to 5 is linked to higher pharmaceutical and medical care costs (Reddy et 
al., 2012). A national probability survey in the United States conducted by the Agency for 
Healthcare Research and Quality Children to compare overweight children with 
normal/underweight children, reported that children who were obese during both years of the 
Medical Expenditure Panel Study (MEPS) had $194 higher outpatient visit expenditures, $114 
higher in prescription drug expenditures, and $12 higher emergency room expenditures. 
Children who were overweight during both years, or overweight in one year and obese in the 
other had $79 higher outpatient visit expenditures, $64 higher prescription drug expenditures, 
and $25 higher emergency room expenditures than normal/underweight children (Trasande & 
Chatterjee, 2009). The results showed a statistically significant difference (p=0.025) level 
across all 6-19-year-old children.  
25 
 
2.5.3.2  Interventions needed for childhood overweight and obesity 
Early intervention and behavioural change is needed during a child’s formative years such as 
better lifestyle choices, promotion of physical activities, better food choices and avoidance of 
exposure to high sugar food advertisements for the prevention of childhood overweight and 
obesity (Desai et al., 2012). In an effort to decrease adult obesity, it is essential to conduct 
early screening of children to prevent overweight or obesity in adulthood (van der Merwe, 
2012). Well-designed studies that produce useful data are needed to develop evidence-based 
policies for the preventative management of childhood overweight and obesity.  
Gillmann et al., (2003) reported physical inactivity, watching television and energy intake as 
the main contributing factors to childhood weight and that the link between GDM and childhood 
obesity was largely reduced when maternal obesity was well controlled. This highlights the 
importance of high maternal BMI as a risk factor for childhood obesity. Overweight in 
adolescents associated with GDM mothers, had an adjusted OR of 1.1 (95% CI: 0.5-2.3), 
whereas in participants without a maternal history of GDM, the OR was 1.3 (95% CI: 1.1-1.5) 
(Gillman et al., 2003) but results were not statistically significant. However, the study did not 
include a diverse group of participants, 93% of whom were from one ethnic group (Gillmann et 
al., 2003). Excluding pre-gestational diabetic mothers contributed to the rigour of this study.  
Changing behavioural patterns is not easy. One approach is the use of constructs such as The 
Health Belief Model (HBM) which was developed as a tool to help researchers understand 
preventative health behavior in a systematic way (Rosenstock, Strecher & Becker, 1988). It 
was developed in the 1950s by USA social psychologists Hochbaum, Rosenstock and Kegels. 
Constructs of the HBM (perceived susceptibility, perceived severity, perceived benefits, 
perceived barriers, cues to action, self-efficacy) have the potential to be used to investigate 
and explain risk factors associated with overweight and obesity in children between 5 and 6 
years of age who were exposed to GDM. The HBM also has the potential to explain and predict 
health behaviors that lead to overweight and obesity in mothers of large for gestational age 
infants and preschool children exposed to GDM. 
2.6 Summary 
There is published evidence that childhood overweight and obesity is on the increase. 
However, studies on the prevalence of overweight and obesity in 5-6-year olds in Africa are 
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scarce. For this minor study a review of the published literature addressed the three research 
questions: what is the prevalence of 1) overweight at birth of infants (macrosomia) exposed to 
GDM during pregnancy; and of 2) overweight and obesity in this cohort 5 to 6 years later; and 
3) what are the risk factors associated with overweight and obesity in these children? A South 
African study showed a GDM prevalence of 15% but there is a paucity of published data from 
South Africa and the Western Cape in particular on the prevalence of GDM, risk factors 
associated with developing GDM and the outcomes of GDM on exposed children.  
GDM has been linked to fetal macrosomia in exposed infants and during the past decade there 
has been a significant global increase of high birth weight in babies associated with GDM. The 
evidence is inconclusive on the difference in the prevalence of overweight and obesity between 
GDM exposed children and non-GDM exposed children. Risk factors that contributed to 
overweight and obesity in children include gender and ethnicity, low maternal education and 
sedentary lifestyle, maternal overweight, high birth weight, exposure to a hyperglycemic 
intrauterine environment and exposure to GDM in utero.  
In Africa, childhood overweight and obesity is on the rise and nearing epidemic proportions. It 
is clear that more research is needed to determine the prevalence of overweight and obesity 





Chapter 3  METHODS 
3.1 Introduction 
This is a sub-study of a larger study that is investigating the progression to type 2 diabetes 
mellitus (T2DM) in women managed for GDM during 2010 and 2011. The sub-study 
investigated anthropometry and overweight and obesity in the offspring of these women 5 to 6 
years after their birth. Due to the lack of local data on the prevalence of overweight and obesity 
in children exposed to GDM in the Western Cape, South Africa, this sub-study filled a gap in 
knowledge to enable health professionals to improve patient outcomes with appropriate 
interventions and to help policymakers formulate appropriate policies to prevent overweight 
and obesity in high-risk children.   
This chapter describes how the sub-study was conducted to achieve the aims and objectives: 
study outcomes, design, sampling, setting, data collection, management and analysis and 
ethical guidelines. 
3.2 Study Outcomes 
3.2.1 Primary outcome 
The primary outcome of the sub-study was to investigate the prevalence of macrosomia at birth 
of infants born from GDM complicated pregnancies in Cape Town during 2010/2011 and the 
prevalence of overweight and obesity in these children in 2016, at age 5 or 6 years as 
measured by their age-specific body mass index (BMI) and Z-scores. Overweight and obesity 
were derived from anthropometric measurements of weight and height. 
Overweight and obesity were defined according to WHO growth standards. For this sub-study, 
Z-scores were defined as a numerical measurement that represented a value that was related 
to the mean (a score of zero). The Z-score could be positive (above the mean) or negative 
(below the mean) by a certain deviation (Dinsdale, Ridler & Ells, 2011). The Z-score deviation 
was used and compared to the WHO 2007 Child Growth Reference Standard to determine if a 
child was overweight or obese based on the child’s calculated BMI expressed as a Z-score or 
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centile. Overweight was taken as weight and BMI z-scores between 1 and 2 and obesity as 
weight and BMI Z-scores above 2 (WHO, 2016). 
All participants had anthropometric measurements standardized according to the WHO 
standard for weight based on their defined Z-scores for this sub-study. Calculations of 
overweight and obesity were based on the following criteria: 
1. Weight for age and gender 
2. Height for age and gender 
3. BMI for age and gender 
 
In addition to weight and height at 5 or 6 years of age, ancillary anthropometric 
measurements (birth weight, birth length and birth head circumference) were reported from 
recorded data. Z-scores for all the anthropometric measurements at age 5 or 6 years were 
reported. 
3.2.2 Secondary outcome 
The secondary outcome was to identify the risk factors associated with overweight and obesity 
in 5 and 6-year old children born from GDM complicated pregnancies. Potential factors, 
maternal (socio-demographic, anthropometric and clinical) as well as child related (clinical and 
socio-demographic) were measured and tested for their association with risk of overweight and 
obesity. 
3.3 Research Study Design 
We used a cross-sectional design to achieve the aims of this research. Cross-sectional studies 
are appropriate for estimating the prevalence of a condition, and in this case our main aim was 
to estimate the prevalence of macrosomia, overweight and obesity in these children (Sedgwick, 
2014). Additional advantages are that cross-sectional designs are relatively quick and easy 
(Mann, 2003) and allow one to measure multiple exposures and outcomes at the same time 
(Sedgwick, 2014).   
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3.4 Study Setting 
The larger study was conducted at the Groote Schuur Hospital (GSH), a referral hospital in an 
urban setting in the Western Cape. At the time the sub-study was undertaken the larger study 
was ongoing. GSH is a large government-funded tertiary academic hospital that serves as a 
referral care center for large population drainage areas in the Western Cape. High-risk 
pregnant women, including those with GDM, are referred from primary care centers for further 
management. GSH is one of the two largest referral hospitals in the Western Cape. 
3.5 Study Population  
The population in the larger study was women managed for GDM during the period November 
2010 to November 2011 at GSH. In this sub-study, the population was defined as 5 to 6-year-
old offspring of these women, who were resident in the Western Cape of South Africa. 
3.6 Sampling and sample size 
The total number of women who were managed for GDM at the GSH between November 2010 
and November 2011 was 498 (Figure 3.1, flow chart of the PRO2D, larger study and sub-
study). Since this population is finite, a total sampling approach was adopted for the larger 
study, where an attempt was made to trace and recruit all 498 women who were willing to 
participate in the larger study to limit selection bias. Since data for this sub-study was from the 


















Figure 3.1: Flow chart of the sub-study nested within the PRO2D larger study 
Data in Figure 3.1 show that for the sub-study there were n=177 possible mother-child 
participants, but n=43 were excluded: 33 mothers did not bring their school attending children 
for the appointment, 5 children had weight but not height measurements, 1 child died during 
infancy and 4 children moved away to live in another province.  
n=498 eligible women identified from an existing hospital 
registry 
Excluded (n=234) 
Contact details no longer 
valid  
n=264 contacted via either telephone or home visit 






Excluded from the larger 
study (n=44): 
 Relocated (n=11) 
 Deceased) n=3) 
 Pregnant (n=5) 
 Refused to participate 
(n=3) 
 Failed to find time for 
the study (n=22) 
n=177 of 220 participants recruited for the PRO2D were 
included in the sub-study 
n=134 with data on height and weight at 5-6 years follow-up 
n=43 excluded: 
 Children at school 
during data 
collection, n =33  
 Children with weight 
but no height 
measurement, n=5 
 Infant death n=1 




3.6.1 Eligibility Criteria 
3.6.1.1 Inclusion Criteria 
Child participants for the sub-study were eligible for inclusion if: 
a. born from a GDM complicated pregnancy to women managed at the Groote Schuur 
Hospital between November 2010 and November 2011; 
b. aged between 5 and 6 years; and 
c. resident in the Western Cape province of South Africa. 
3.6.1.2 Exclusion Criteria 
Child participants were excluded who: 
a. were critically ill or had a terminal illness such as cancer;  
b. had congenital malformations.  
3.6.2 Sample Size 
Although the sub-study used a total sampling approach, a sample size calculation was 
nevertheless performed to determine whether the primary objective of the sub-study would be 
achieved. The sample size for the sub-study was calculated using a hypothesized proportion 
of overweight pre-scholars of 29% found in a study by Baptiste-Roberts et al., 2012 (although 
these researchers investigated 7-year olds and not 5 to 6-year olds). Using this 
hypothesized proportion and aiming for a precision of 9% either side of the hypothesized 
proportion, the estimated sample size for the sub-study was 156 children. This was the 
minimum sample size required to estimate the prevalence of overweight and obesity. Since 
the main aim of the study was to estimate prevalence, using data from all the available 
children would not have affected this objective. 
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3.7 Data collection  
This section deals with the construction and validation of data collection instruments, 
measurement equipment and standards, data collection procedures, data management and 
analysis. 
3.7.1 Construction of data collection instruments  
In the larger study, those mothers who agreed to participate in the study were interviewed using 
a structured questionnaire (Appendix A). For the sub-study, pertinent data were extracted from 
those questionnaires using a structured data collection form (Appendix B). The data collection 
form consisted of two sections: one for maternal information and one for the child’s data (age, 
type of delivery, birth weight, any hospitalizations of the child for ≥ a week). It had sub-sections 
for specific data, for example, personal information, demographics, and medical history. 
Additional clinical and medical history data were collected from the mothers’ hospital files 
(Section 3.7.5). 
3.7.2 Measurement tools and standards 
In the sub-study, all measurements were carried out using standardized techniques and 
equipment. A balanced digital scale for weight and a fixed wall-mounted stadiometer for height 
measurements for mother and child were used in a clinical setting. The results were recorded 
on the questionnaire (Appendix A) and the data extraction form for the sub-study (Appendix 
B). The weighing scale was calibrated and standardized using the weight of a known mass (a 
5 kg weight) prior to weighing the children. A portable stadiometer was used for field visits 
when required. Each measurement was made according to prescribed standards (Bowring et 
al., 2012).  
3.7.3 Reliability and validity testing 
In the larger cross-sectional study, prior to data collection, the principal investigator trained all 
field staff on the procedure for administering the questionnaire and taking anthropometric 
measurements. Field staff were also trained on standard operating procedures (SOPs) and 
given electronic and hard copies thereof. To ensure reliability of anthropometric 
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measurements, all measurements were taken by competent and trained researchers using the 
same standards for all participants. 
The questionnaire for the larger study was piloted among 20 hospital staff who came from the 
same neighbourhood as the participants. Their role was to check for any inconsistencies, 
unclear meanings and any ambiguities in the data. The field staff were trained in anthropometry 
one month beforehand and coefficients of variation calculated, until the coefficients of variation 
were very small. For the questionnaire, field staff members were trained using a prepared 
manual on each section and the questions within the sections. Most of the sections in the 
questionnaire used in the larger study were from previously validated measuring tools.  
To ensure that the study was rigorous and reliable a strict set of procedures and protocols were 
followed during the data collection phase while using peer reviews and audits throughout the 
data collection process. At the completion of each questionnaire, a second interviewer double-
checked the questionnaire for completeness and obvious errors.  
For the sub-study, data extracted from the questionnaire (Appendix A) used in the larger study 
were recorded on a pre-tested data collection form (Appendix B). In addition, to validate the 
data collected and improve data reliability, a second investigator rechecked all data on the data 
collection form. 
3.7.4 Recruitment and data collection procedure 
3.7.4.1 Structured interviews with participant mothers 
In the larger study, all potential participants were first identified from an existing hospital register 
of all women managed for GDM between November 2010 and November 2011. Those 
identified and eligible were first contacted telephonically (using a prepared and pretested 
telephonic script) and recruited for participation in the sub-study. If these mothers were not 
reached with the first call, a voice message was left, or an alternative number was called if 
available. If the mother was not reachable, a further three attempts were made to reach her. 
House visits were also made, to addresses listed in the hospital record to reach mothers whose 
telephonic contact details might have been out of date.  
When contacted, the potential participants (mothers) were informed about the purpose and 
procedures involved in the larger study and once fully informed, were asked to participate in 
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the study. If the mothers agreed to participate in the larger study, recruitment of child 
participants for the sub-study followed by informing the mothers about the purpose and 
procedures involved in the sub-study. The children were asked to assent to have their height 
and weight measured. Willing participants (mothers) for the larger study were then invited to 
bring their children who met the inclusion criteria with them for participation in the sub-study. 
The mothers were informed that only the children’s weight and height would be taken and were 
given information about the venue. 
Following recruitment, data collection for the larger study and the sub-study commenced on 01 
May 2016 and ended on 30 April 2017 and took place on the same day as the interview. In 
cases where children were absent during the data collection process, the mothers agreed to 
have the children’s height and weight taken later. Follow-up calls were made to obtain the 
missing data. In the larger study, the mothers who had agreed to participate in the study were 
interviewed using a structured questionnaire (Appendix A). The mother provided information 
about herself and her child. For the sub-study, pertinent data not obtained from the mothers 
were extracted from the questionnaires using a structured data collection form (Appendix B).  
Clinical and demographic characteristics obtained from the larger study (Appendix A) and 
interviews included data about the children: ethnicity, type of delivery, breastfeeding and 
duration, hospitalization, current chronic medication and number of siblings. Maternal data 
included: age, marital status, number of adults in the house, level of education, employment, 
number of antenatal visits, BMI at booking, fasting plasma glucose during pregnancy, height, 
weight, current BMI, history of smoking, electricity in the home, ownership of the home, type of 
dwelling and availability of tap water. 
3.7.4.2  Anthropometric Measurements 
Anthropometry refers to the scientific study of the measurements of the human body. In this 
sub-study, the children’s anthropometric measurements were taken (weight and height at ages 
5 or 6 years).  Before any measurements on children were taken, mothers were asked for 
written informed consent and they and their children were reassured that no physical discomfort 
would be caused while taking the child’s weight and height. Mothers were informed that they 
and their children can withdraw their participation from the study at any time during the process 
without losing incentives for travel. A time for questions was allowed before written consent 
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was obtained voluntarily from the mother. The mother signed two consent forms: one for herself 
and one for her child’s participation. These forms were retained by the researcher, but the 
mother was given a copy of both the informed consent and the information sheet with the 
contact details of the researchers. 
Anthropometric measurements of the children and the mothers were taken at the GSH Clinical 
Research Centre. If the child was not present, arrangements were made for the researcher 
and a research assistant to obtain the child’s anthropometric measurements at either their 
school or home with the consent of the mother.  
Height was measured using a fixed stadiometer. Each child was asked to stand up straight 
against a wall with their bare heels touching the wall, arms at their side and their heads up by 
looking straight forward. Measurements were taken to the top of the child’s head. The value of 
each child’s height was recorded to the nearest 0.1 cm.   
The child’s weight was taken using a calibrated electronic scale. Body mass was measured 
with children wearing light clothes and light, flat shoes (Bowring et al., 2012). If shoes appeared 
to be heavy or high, the child was asked to remove them before measurement of weight or 
height was taken.  Each child was asked to stand still, with body weight equally distributed on 
the calibrated scale. When the scale reading stabilized, the body weight was recorded to the 
nearest 0.1 kg (Bowring et al., 2012). To reduce the risk for error in documenting the 
anthropometric measurements the weight and height of each child was verbally reported to the 
mother and research assistant and immediately documented in the file of the participant.  
3.7.5 Hospital records review 
For purposes of the sub-study data on birthweight, birth length, head circumference and 
mother’s OGTT results at the time of GDM diagnosis were cross-checked against hospital 
records. Additional data from hospital records included the child’s date of birth, and gestational 
age at delivery. The child’s age was verified from the birth certificate when necessary. If 
needed, the children’s Road to Health book given to parents at the birth of a child in South 
Africa, was used to verify information.  
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Additional clinical and demographic characteristics of the study participants and selected 
characteristics of their mothers were obtained from hospital records and data from the larger 
study (Appendix A):  
3.8 Data management and analysis 
3.8.1 Data management 
Sensitive data such as the participant’s name and contact details were treated confidentially, 
and access restricted. All research data were secured in a locked storage box and in a lockable 
file cabinet, in a locked room. In addition, electronic data (i.e. computers, memory sticks, CD-
ROMS, etc.) were physically secured and password protected.  
Data were captured as accurately as possible while data entry errors were minimized by having 
a co-researcher check each completed questionnaire for errors and omissions. The collected 
data from the questionnaires were entered onto a Microsoft Office Excel 2016 spreadsheet by 
using an anonymous identifier for each participant and using double data entry. All data were 
backed up daily on external media for safe-keeping and prevention of accidental loss. 
3.8.2 Statistical Data analysis 
Data were captured on Microsoft Excel spreadsheets and analysis was carried out using Stata 
14 (StataCorp, 2015). Categorical variables were reported as proportions and frequencies. All 
data measured were first tested for normality using the Shapiro-Wilks test and histograms. 
Medians and interquartile ranges (IQR) were reported for skewed measured data, while means 
and standard deviations (SD) were reported for normally distributed measured data. A two-
sided P<0.05 was considered as significant while 95% confidence intervals were reported for 
all estimates. 
Z-scores were used to standardize the weight, height and BMI, using WHO growth 
standards for the ages 5 to 6 years. Mean Z-scores and standard deviations were reported 
if the Z-sores were normally distributed. If the Z-scores were not normally distributed, the 
median and interquartile ranges were reported.  
The prevalence of overweight and obesity were calculated as a proportion, the total number of 
overweight/obese children over the total number of participants. To determine the risk factors 
associated with the outcome (overweight and obesity, treated as a binary variable), the 
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appropriate hypothesis tests were used, using a 5% significance level. The chi squared test 
and its variants were used to determine univariate associations between categorical variables 
and the outcome, defined as overweight or obesity (a binary outcome; either BMI Z-score >1 
or BMI ≤1). T-tests, ANOVA and their non-parametric equivalents were used to test univariate 
associations for numerical data.  
Manual logistic regression was used to adjust for multivariate associations as well as 
confounding factors associated with overweight and obesity. Intelligent manual backward 
stepwise logistic regression was used with a 0.3 level of significance for entry. Initially, all 
variables with P-values of 0.3 and below were included in the model. Model testing and 
diagnostics included checking for multicollinearity, model specification, Hosmer Lemeshow 
goodness of fit test, Lineality assumption between the log odds of overweight and obesity and 
the covariates as well as checking for influential cases. The Lowes graph to test the Lineality 
assumption showed some reasonable linear relationship although not satisfactory. We 
checked for multicollinearity using Variance Inflation factors (VIFs) and the results show VIFs 
less than 3 (mean 1.46) and this suggested no concern for multicollinearity while the linktest 
(P=0.09) and the Hosmer Lemeshow goodness of fit test (P=0.078) suggested that the model 
fits the data to a reasonable extent. Only one influential case was identified and checking the 
data of the child reviewed no errors. 
3.9 Ethical Considerations 
Ethical approval (UCT HREC 656/2015) for the larger study was granted by the University of 
Cape Town, Faculty of Health Sciences Human Research Ethics Committee (Appendix B). 
Ethical approval for this sub-study (UCT HREC 826/2016) was also granted by this Committee. 
Approval to gain access to the research site and participants was granted (Appendix C). The 
legal and regulatory standards and protocols were adhered to as stipulated in the Declaration 
of Helsinki ( 2014). 
Before the start of the larger study, participant’s mothers were briefed about the study and the 
purpose of the research. The researchers explained to all mothers that no harm will result from 
the study and that the researchers would always act in their best interests. For the sub-study 
the mothers were asked for permission to have their children weighed and their height 
measured, while the children were asked verbally (after explaining the process) for their assent. 
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It was explained that risk for injury was minimal, and the mother could be present while 
measurements of the child were being taken. Furthermore, if the child did not want to be 
weighed, they were not forced to participate. None of the children refused to have their heights 
and weights measured. 
In the parent study, all the mothers were clearly informed that participation in the study was 
strictly voluntary and anyone could have opted out of the study at any time without any 
consequences. The mothers were also informed they would receive a stipend for travel costs 
and food voucher even if the child refuse to be weighted or measured. Mothers of all children 
signed a written informed consent form prior to participating in the sub-study (see Consent form 
in Appendix I). All participants’ information was protected and secured. 
3.10 Summary 
In this chapter, a description and discussion of the sub-study methodology was provided. The 
sub-study was part of a larger cross-sectional study. The study setting, population, eligibility 
criteria, sampling process, construction of the data collection tool and standards used as well 
as the processes for data collection, data management and statistical analyses were 




Chapter 4 RESULTS 
 
4.0 Introduction 
In this chapter, the results of the sub-study are presented. The primary outcome of the sub-
study was to investigate the prevalence of macrosomia at birth of infants born from GDM 
complicated pregnancies in Cape Town during 2010/2011 and the prevalence of overweight 
and obesity in these children in 2016, at age 5 or 6 years as measured by their age-specific 
body mass index (BMI) and Z-scores. Overweight and obesity were derived from 
anthropometric measurements of weight and height.  
The secondary outcome was to identify the possible risk factors associated with overweight 
and obesity in the same cohort of 5 to 6-year-old children. One hundred and seventy-six 
participants comprising n=78 boys (44.3%) and n=98 girls (55.7%) were recruited. Clinical and 
demographic characteristics of the study participants and selected characteristics of their 




Table 4.1:  Clinical and demographic characteristics of the participants and their 
mothers 
Characteristics Overall, N = 
176 (100%) 
Boys, N = 78 
(44.3%) 
Girls, N = 98 
(55.7%) 
P-value 
CHILDREN     
Age, median (IQR) years, N=165 5.4 (5.1-5.8) 5.4 (5.0-5.7) 5.5 (5.1-5.9) 0.18 
Ethnicity* n (%) N=170    
0.52 
Black 51 (30.0) 24 (31.6) 27 (28.7) 
Coloured 111 (65.3) 47 (61.8) 64 (68.1) 
White 4 (2.4) 3 (3.9) 1 (1.1) 
Asian 3 (1.8) 1 (1.3) 2 (2.1) 
Other 1 (0.6) 1 (1.3) 0 (0.0) 
Gestational age at birth, median (IQR), 
weeks, n=174 
38 (37-39) 38 (37-39) 38 (37-39) 0.98 
Type of Delivery, n (%), N=174    
0.75    Vaginal Delivery 







Breastfed, n (%), N=173 137 (79.2) 60 (77.9) 77 (80.21) 0.63 
Breastfeeding length, median (IQR), 
days N=123 
51 (12.8-102) 51 (12.8-102) 34 (12.8-102) 0.60 
Child history of ever being 
hospitalized for at least 1 week, n 
(%), N=166 
14 (8.4) 7 (9.3) 7 (7.7) 0.88 
Children currently on chronic 
medication n (%), N=162 
8 (4.9) 4 (5.4) 4 (4.6) 0.80 
Number of Siblings, median (IQR), 
N=176 
2 (1-3) 2 (1-3) 2 (1-3) 0.51 
MATERNAL     
Maternal age at 5-6 years follow-up 
median (IQR), N=176 
36 (32-40) 36 (31-40) 36 (32-40) 0.68 
Marital status at 5-6 years follow-up, 
n (%), N=172 


















Number of adults in house, median 
(IQR), N=170 
2 (1-3) 2 (1-3) 2 (1-3) 0.97 
Mother education, at 5-6 years follow-
up, n (%), N=171 
   
0.66 
Never went to school 
Grade 1 to 7 (Primary school) 
Grade 8 to 10 
Matric 


















Characteristics Overall, N = 
176 (100%) 
Boys, N = 78 
(44.3%) 
Girls, N = 98 
(55.7%) 
P-value 
Mother employment at 5-6 years 
follow-up, n (%), N= 165 
   
0.32 
Employed, salaried  75 (45.5) 34 (47.9) 41 (43.6) 
Self-employed  
Unemployed    
A full-time homemaker  
A pensioner 








 4 (4.3) 
0 (2014) 






Number of Antenatal visits, median 
(IQR), N=38 
7 (3.7-39) 9 (7-11.5) 8 (6.05-10) 0.03* 
Maternal BMI at booking median (IQR) 
N=119 





Mother fasting plasma glucose during 
pregnancy, mmol/l of measurement 
median (IQR), N=142  
5.7 (5.1-6.4) 5.6 (5-6.4) 5.7 (5.1-6.4) 0.49 
Mother OGTT 2 Hour Glucose during 
pregnancy, mmol/l median (IQR), 
N=133 
8.8 (8.2-9.7) 8.6 (7.9-9.3) 8.9 (8.3-10) 0.08 
Mother height, 5-6 years post GDM 
median (IQR), cm, N=173 
161 (157-165) 161 (157-164) 160.7 (157-
165.3) 
0.64 
Mother weight 5-6 years post GDM, 
median (IQR), kg, N=167 
87.7 (74- 107.2) 87.4 (74.1-
103.2) 
89 (74-109) 0.82 
Mother BMI 5–6 years post GDM, 
median (IQR), kg/m2, N=167 
34.2 (29.2-39.1) 34.2 (28.8-38.6) 34.2 (29.4-
40.5) 
0.90 
Mother smoked at 5-6 years post 
GDM, n (%) N=170,  
57 (33.5) 49 (64.5) 64 (68.1) 0.62 
Mothers have electricity in house, n 
(%) N=172   
169 (98.3) 74 (97.) 95 (98.9) 0.43 
Mothers own house, n (%) N=164 54 (32.9) 20 (27.0) 34 (37.8) 0.15 
Type of house, n (%) N=165:   
Built formal unit  








Tap-water, n (%) N=172 171 (99.4) 76 (100) 95 (98.9) 0.37 
Shared tap-water, n (%) N=168 26 (15.5) 13 (17.8) 13 (13.7) 0.25 
 
Note to table: *A significance level of 0.05 was assigned for statistical significance 
* South African race classification  
IQR = interquartile range; SD = standard deviation; OGTT = oral glucose tolerance test; GDM 
= Gestational Diabetes Mellitus 
Table 4.1 shows the demographic and some clinical characteristics of the children (at birth and 
at 5 to 6 years of age) and their mothers. In terms of the South African race classification, the 
majority of children were Coloured (n=111, 65.2%), 51 (30%) were Black, 4 (2.4%) were White, 
3 (1.8%) were Asian and ‘Other’ accounted for 1 (0.6%). The median gestational age at birth 
of the children was 38 (37-39) weeks, while during follow-up, the median age of the children 
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was 5.4 (IQR, 5.1-5.8) years. The number of children who were breastfed was 137 (79.2%) 
while 8 (4.9%) were taking medications for chronic illnesses. In response to a question in the 
larger study about the number of children who were hospitalized for at least one week, mothers 
reported that very few children (n=14, 8.4%) had been hospitalized. More than half of the 
children (n=96, 55.2%), were delivered via caesarian section.  
During pregnancy, the mother’s median BMI at booking was 34.9 kg/m2 (IQR, 28.5-42.7), while 
their median fasting glucose at GDM diagnosis was 5.7 (IQR, 5.1-6.4) mmol/l and the median 
2-hour OGTT result was 8.8 (IQR, 8.2-9.7) mmol/l. The overall median number of antenatal 
visits for each mother was 8.4 (IQR, 7-11) visits. At 5 to 6 years’ post GDM, the median BMI of 
the mothers was 34.2 (IQR, 29.2-39.1) kg/m2. At 5 to 6 years post-GDM, more than half (n=113, 
65.7%) of the mothers were married, while the majority (n=82, 47.6%) had an educational level 
of Grade 12 (matric) (the highest level) and 26 (15.2%) had a tertiary education. Seventy-five 
(45.5%) mothers were employed. Fifty-seven mothers (33.5%) had a history of smoking. The 
majority (n=169, 98.3%) had electricity in the home which comprised a formal built unit (n=118, 
71.5%) and access to their own supply of tap water (n=171, 99.4%). There were no statistically 
significant differences in most of the variables between the boys’ and girls’ mothers except in 
the number of antenatal visits. The median number of antenatal visits for the boys’ mothers 
was 9 (IQR, 7-11.5) during the pregnancy and for the girls’ mothers this was 10 (IQR = 8-3) 
(p=0.03) visits.  




4.1 Objective 1: To describe anthropometric characteristics of infants exposed to 
GDM during pregnancy in the years 2010 and 2011 at Groote Schuur Hospital 
(GSH) and of the same cohort of 5 and 6-year-old children 
Anthropometric measurements at birth (median, IQR) are presented in Table 4.2. 
Table 4.2: Anthropometric characteristics at birth 
Characteristics Overall, N =176 Boys, N= 78 Girls, N = 98 P-value 
Gestational age at birth, median 
(IQR), weeks, N=174 
38 (37-39) 38 (37-39) 38 (37-39) 0.98 
Birth weight, median (IQR), gm, 
N=54 
3295 (2985-3600) 3262.5 (2922.5-3595) 3295 (3000-3620) 0.57 
Birth length, median (IQR), cm 
N=54 
50 (45-53) 50 (45-52) 51 (47-53) 0.60 
Head circumference at birth, 
median (IQR), cm, N=74 
34 (33-35.5) 33 (32-34) 34 (33-36) 0.02* 
Note to table: *A significance level of 0.05 was assigned for statistical significance 
Gestational age at birth was 38 (IQR, 37-39) weeks (2 missing data), birth weight was 3295 
(IQR, 2985-3600) grams (122 missing data), length at birth was 50 (IQR, =45-53) cm (122 
missing data) and head circumference was 34 (IQR, =33-35.5) cm (102 missing data). Except 
for head circumference (p=0.02) there were no statistically significant differences between the 





4.2 Objective 2: To describe anthropometric characteristics of the cohort of children 
exposed to GDM during pregnancy in the years 2010 and 2011 at Groote Schuur 
Hospital (GSH) at ages 5 and 6 years 
Table 4.3: Anthropometric characteristics of GDM exposed children aged 5 to 6 years 
Characteristic Overall, N = 176 Boys, N= 77 Girls, N = 98 P-value 
Child Height, mean (SD), cm, n=138 112.14 (5.72) 112.04 (5.84) 112.29 (5.66) 0.78 
Z-score for height, mean (SD) 0.013 (1.07) 0.008 (1.08) ( 0.017 (1.11) 0.97 
Child Weight, median (IQR), kg, 
n=143 
19.3 (18-23) 19.2 (18-21) 19.75 (18-23) 0.50 
Z-score for weight, mean (SD) 0.278 (1.40) 0.145 (1.38) 0.390 (1.41) 0.31 
Child BMI, median (IQR), kg/m2, 
n=138 
15.7 (14.5-17.2) 15.7 (14.5-16.7)  15.8 (14.5-18.0) 0.46 
Z-score for BMI, mean (SD)  0.365 (1.63) 0.218 (1.72) 0.485 (1.55) 0.35 
Note to table: A significance level of 0.05 was assigned for statistical significance 
Data in Table 4.3 present anthropometric characteristics of GDM exposed children aged 5 to 
6 years, and a comparison between boys and girls. Data for height were normally distributed 
but not for weight. Measures of central tendency and dispersion of data for height are therefore 
shown as mean (SD) respectively and for weight as median (IQR) respectively. The mean (SD) 
height was 112.1 (5.7) cm, median (IQR) weight was 19.3 (18-23) kg and the median (IQR) 
BMI at 5 and 6-years old was 15.7 (14.5-17.2) kg/m2. The mean (SD) Z-score for height was 
0.013 (1.07), 0.278 (1.40) for weight and 0.365 (1.63) for BMI. Graphic presentation of the data 
can be found in Appendix D. There were no statistically significant differences between the 




4.3 Objectives 2 and 3: To describe the proportion of fetal macrosomia and the 
prevalence of overweight and obesity 5 to 6 years later 
Results for the proportion of macrosomia and the prevalence of overweight and obesity 5 to 6 
years later are presented in Table 4.4. 
Table 4.4: Proportion of macrosomia and prevalence of overweight and obesity at 5 to 6 
years of age 
Characteristic Category Overall, N=138 Boys, N = 75 Girls, N =63 P-
value 
n (%) 95% CI n (%) 95% CI n (%) 95% CI  














44 (73.3) 60.4-83.2 49 (66.2) 54.4-76.2 0.49 
Overweight, 
(BMI z score 
more than 1 but 
less than 2)  
18 (13.4) 8.6-20.4 5 (8.3) 3.4-18.9 13 (17.6) 10.4-28.2 
Obese, (BMI Z-
score >2)  
19 (14.2) 9.2-21.2 9 (15.0) 7.8-26.8 10 (13.5) 7.3-23.6 
Underweight, 
(BMI<1) 
4 (2.9) 1.1-7.8 2(3.3) 0.8-12.8 2 (2.7) 0.7-10.4 





45(71.4) 58.7-81.4 49 (65.3) 53.7-75.4  
Overweight, 
(weight z score 
more than 1 but 
less than 2) 
17 (12.3) 7.7-19.0 5/63 (7.9) 3.2-18.1 12 (16.0) 9.1-26.4 0.37 
Obese, (weight 
Z-score >2)  
21 (15.2) 10.0-
22.3 




6 (4.4) 1.9-9.4 4 (6.4) 2.3-16.1 2 (2.7) 0.6-10.3 




(75.2)       
67.0-
81.8 




4 (3.0) 1.1-7.8 1 (1.7) 2.2-11.5 3 (4.1) 1.2-12.2 




11 (18.3) 10.3-30.6 12 (16.4) 9.4-27.0 
short (height Z-
score<1)  
6(4.5) 2.0-9.7 4(6.7) 2.5-16.9 2 (2.7) 6.6-10.6 
Note to table: A significance level of 0.05 was assigned for statistical significance. 
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Table 4.4 shows the data on weight (at birth and at ages 5 to 6 years), height (at ages 5 to 6 
years) and BMI categories (at ages 5 to 6 years) as categorized using the WHO Z-scores for 
children. At birth, the overall prevalence of macrosomia was 12.3% (95% CI 8.1%-18. 2%). 
Using BMI Z-scores, the prevalence of overweight was 13.4% (95% CI 8.5%-20.4%) while the 
prevalence of obesity was 14.1% (95% CI 9.2%-21.3%). When only weight Z-scores were 
used, the overall prevalence of overweight dropped slightly to 12.3% (95% CI 7.6%-19.0%), 
while the prevalence of obesity rose slightly to 15.2% (95% CI 10.1-22.3%). The overall 
prevalence of children who were tall for their age (1<height Z-score<2) was 3.0% (95% CI 
1.1%-7.8%), while the overall prevalence of children who were too tall for their height (height 
Z-score >2), was 17.3% (95% CI 11.7%-24.8%). There were no significant differences 
between the boys and girls in the prevalence of overweight and obesity as measured by the 
Z- scores cut-offs of any of the anthropometric measures (Table 4.4). 
4.4 Objective 4: Risk Factors Associated with Overweight and Obesity in Children 
exposed to GDM 
Data for risk factors associated with overweight and obesity in the cohort of 5 and 6-year-old 




Table 4.5:   Risk factors for overweight and obesity (BMI Z-score ≥1) 












95% CI P-value 
Child Birth weight 
(g) 







Child age 5-6 
years post GDM  







Child Gender, n 
(%) 
Boys  46 (76.7) 14 (23.3) 0.32 0.76 0.15-3.89 0.75 
 Girls 51 (68.9) 23 (31.1)  1   
Child Head 
circumference (cm) 
Median (IQR) 34 (32-35) 35 (32.5-
36.5) 
 
0.17    
Child Birth length 
(cm) 
Median (IQR) 50 (44-52) 51.25 (47-54) 0.39    
Child Gestational 
age at birth 
Median (IQR) 38 (37-39) 38 (37-39) 0.42    
Child Ethnicity Black, n (%) 22 (57.9) 16 (42.1) 0.02 
 
4.52 0.7-277.4 0.47 
 Coloured, n 
(%) 
71 (80.7) 17 (19.3) 1.15 0.3-40.7 0.94 
 White & 
Others, n (%) 
4 (57.1) 3 (42.9) 1   
Type of birth 
delivery 
Vaginal, (n %) 50 (78.1) 14 (21.9) 0.18 0.65 1.2-3.6 0.58 
 Caesarian 
section 
46 (67.6) 22 (32.4)     
Child breastfed 
(any length) days 
Yes n (%) 77 (71.9) 30 (28.0) 0.82    
Child on chronic 
medication at age 
5-6 years 
Yes n (%) 6 (75) 2 (25) 0.88    
Child hospitalized 
for at least 1 week 
since birth 
Yes, n (%) 7 (58.3) 5 (41.7) 0.31    
Mother married  Yes n (%) 23 (65.7) 12 (32.4) 0.43    
Maternal age 5-6 
years post GDM 
Median (IQR) 36 (31-40) 37 (34-41) 0.09 1.01 0.86-1.19 0.88 
No. of adults in the 
house 5-6 years 
post GDM 
Median (IQR) 2 (1-3) 2 (1-2) 0.13 0.38 0.17-0.86 0.02* 
No. of siblings in 
the house 5-6 
years post GDM 
Median (IQR) 2 (1-3) 2 (1-3) 0.32    
Maternal BMI at 
booking  














Median (IQR) 9.7 (8.7-10.6) 9.9 (8.4-11.2) 0.32    
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Median (IQR) 8.4 (7.9-9.6) 8.7 (7.9-9.4) 0.001 2.06 1.14-3.74 0.02* 
Mother weight 5-6 
years post GDM 
Median (IQR) 85.3 (72.7-
108.5) 
97 (75-106) 0.27  0.83-1.11 0.62 
Mother height 5-6 
years post GDM 




0.65    
Mother BMI 5-6 
years post GDM 




0.27 0.99 0.87-1.13 0.94 
Mother number of 
antenatal visits  
Median (IQR) 8 (7-11) 8.5 (6-10) 0.70     
Mother Education: 
matric and tertiary 
5-6 years post 
GDM  




5-6 years post 
GDM 
Yes n (%) 40 (70.2) 17 (29.8) 0.47    
Mother Owns a 
house 5-6 years 
post GDM 
Yes n (%) 28 (63.6) 16 (36.4) 0.16 0.58 0.10-3.23 0.53 
Type of house 5-6 
years post GDM 
Formal n (%) 67 (70.5) 28 (29.5)  
0.57 
  \ 
 Informal n (%) 25 (75.8) 8 (24.2)    
Tap-water in home 
5-6 years post 
GDM 
Yes n (%) 96 (72.2) 37 (27.8) 0.72    
Electricity in home 
5-6 years post 
GDM 
Yes n (%) 94 (71.8) 37 (28.2) 0.37    
Shared tap-water 
in home 5-6 years 
post GDM 
Yes n (%) 15 (78.9) 4 (21.1) 0.72    
Toilet in home 5-6 
years post GDM 









Yes n (%) 36 (83.7) 7 (16.3) 0.05 0.38 0.05-2.84 0.38 
Note to table: *A significance level of 0.05 was assigned for statistical significance. 
Birth head circumference and length were omitted from the multivariate analysis model as there 
was a significant amount of missing data. Variables with P-values greater than 0.3 on univariate 
analysis were not included in the multivariate logistic regression model.  
 
Data in Table 4.5 show the potential risk factors that were investigated for their association 
with overweight and obesity, using a BMI Z-score cut-off of 1. All children were categorized as 
overweight or obese (coded 1) if they had a BMI Z-score cut-off of more than one, while all 
children with a BMI Z-score less than or equal to 1 were categorized as normal or underweight 
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(coded 0). Overall, 37/134 (27.6%, 95% CI 20.6%-35.9%) (Table 4.4) children were classified 
as either overweight or obese at ages 5 to 6 years. Variables in Table 4.5 that had a statistically 
significant association with overweight and obesity in 5 and 6-year-old children exposed to 
GDM: birth weight (adjusted OR 1.002, 95% CI 1.0004-1.00, p=0.012), age in years (adjusted 
OR 0.02, 95% CI 0.001-0.29, p=0.004), maternal two-hour plasma glucose during pregnancy 
(adjusted OR 2.06, 95% CI 1.14-3.74, p=0.017) and number of adults in the house 5 to 6 years 
at the time of testing (adjusted OR 0.38, 95% CI 0.17–0.86, p=0.020). A potential risk factor 
was maternal fasting plasma glucose during pregnancy where the P-value approached 
significance (0.06) (Table 4.5). 
4.5 Evaluation of the sub-study 
The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) 
guideline consisting of 22 items for reporting observational studies (EQUATOR Network) was 
used at the end of the sub-study to standardize and enhance the quality and transparency of 
reporting (Lachat et al., 2016) (see Appendix G). 
4.6 Summary 
This chapter presented the results of the sub-study guided by the primary aim of investigating 
the prevalence of overweight and obesity in children at birth and at ages 5 to 6 years born from 
GDM complicated pregnancies in Western Cape, South Africa. Further results presented were 
guided by the secondary aim: to identify the possible risk factors associated with overweight 
and obesity in the same cohort of 5 to 6-year-old children born from GDM complicated 
pregnancies. An analysis of the data for each of the four sub-study objectives is presented.  
The sub-study recruited 176 participants: 78 boys (44.3%) and 98 girls (55.7%). 
Anthropometric measurements at birth (Table 4.2) showed a median gestational age at birth of 
38 (IQR=37-39) weeks, birth weight of 3,295 (IQR=2,985-3,600) grams, birth length of 50 
(IQR=45-53) cm and head circumference at birth of 34 (IQR=33-35.5, p=0.02) cm. Missing 
data for birth weight, length and head circumference was considerable. 
Anthropometric characteristics of GDM exposed children aged 5 to 6 years (Table 4.3) showed 
a mean (SD) height of 112.1 (5.7) cm, median (IQR) weight of 19.3 (8-22.9) kg and median 
(IQR) BMI of 15.7 (14.5-17.2) kg/m2. The mean (SD) Z-score for height was 0.01 (1.07), for 
weight was 0.28 (1.40) and for BMI was 0.37 (1.63).  
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Data on weight at birth and at ages 5 to 6 years, height (at ages 5 to 6 years) and BMI 
categories (at ages 5 to 6 years) were categorized using the WHO Z-scores for children. At 
birth, the overall prevalence of macrosomia (Table 4.4) was 12.3% (95% CI 8.2%-9.1%). Using 
BMI Z-scores, the prevalence of overweight was 13.4% (95% CI 8.6%-20.4%) while the 
prevalence of obesity was 14.2% (95% CI 9.2%-21.2%). When only weight Z-scores were 
used, the overall prevalence of overweight dropped slightly to 12.3% (95% CI 7.7%-19.0%), 
while the prevalence of obesity rose slightly to 15.2% (95% CI 10.0-22.3%). The overall 
prevalence of children who were tall for their age (1<height Z-score<2) was 3.0% (95% CI 
1.1%-7.8%), while the overall prevalence of children who were too tall for their height (height 
Z-score >2), was 17.3% (95% CI 11.7%-24.8%).  
Overall, 37/134 (27.6%, 95% CI 20.6%–35.9%) children were classified as either overweight 
or obese at ages 5 to 6 years (Table 4.4). Variables that had a statistically significant 
association with overweight and obesity in 5 and 6-year-old children exposed to GDM (Table 
4.5) were: the number of adults in the house (adjusted OR 0.38, 95% CI 0.17-0.86, p=0.02), 
birth weight (adjusted OR 1.00, 95% CI 1.00-1.00, p=0.01), age in years (adjusted OR 0.03, 
95% CI 0.002-0.29, p=0.004), and maternal two-hour plasma glucose during pregnancy 
(adjusted OR 2.06, 95% CI 1.14-3.74, p=0.02). A potential risk factor was maternal fasting 
plasma glucose during pregnancy where the P-value approached significance (0.06).   
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Chapter 5 Discussion, Conclusion and Recommendations 
5.0 Introduction and main results 
The sub-study aims and objectives were achieved. The prevalence of macrosomia at birth in 
GDM related pregnancies and overweight and obesity in the cohort of children 5 to 6 years 
later, is of concern. Risk factors associated with overweight and obesity in the participants, a 
cohort of 5 and 6-year old children, were identified. 
The sub-study recruited 176 participants: 78 boys (44.3%) and 98 girls (55.7%). 
Anthropometric measurements at birth (Table 4.2) showed a median gestational age at birth of 
38 (IQR=37-39) weeks, birth weight of 3,295 (IQR=2,985-3,600) grams, birth length of 50 
(IQR=45-53) cm and head circumference at birth of 34 (IQR=33-35.5, p=0.02) cm. Missing 
data for birth weight, length and head circumference was considerable. Anthropometric 
characteristics of GDM exposed children aged 5 to 6 years (Table 4.3) showed a mean (SD) 
height of 112.1 (5.7) cm, median (IQR) weight of 19.3 (8-22.9) kg and median (IQR) BMI of 
15.7 (14.5-17.2) kg/m2. The mean (SD) Z-score for height was 0.01 (1.07), for weight was 0.28 
(1.40) and for BMI was 0.37 (1.63).  
At birth, the overall prevalence of macrosomia (Table 4.4) was 12.3% (95% CI 8.2%-9.1%). 
Using BMI Z-scores, the prevalence of overweight was 13.4% (95% CI 8.6%-20.4%) while the 
prevalence of obesity was 14.2% (95% CI 9.2%-21.2%). When only weight Z-scores were 
used, the overall prevalence of overweight dropped slightly to 12.3% (95% CI 7.7%-19.0%), 
while the prevalence of obesity rose slightly to 15.2% (95% CI 10.0-22.3%). Overall, 37/134 
(27.6%, 95% CI 20.6%–35.9%) children were classified as either overweight or obese at ages 
5 to 6 years (Table 4.4). Variables associated with overweight and obesity in 5 and 6-year-old 
children exposed to GDM (Table 4.5) were: the number of adults in the house (adjusted OR 
0.38, 95% CI 0.17-0.86, p=0.02), birth weight (adjusted OR 1.00, 95% CI 1.00-1.00, p=0.01), 
age in years (adjusted OR 0.03, 95% CI 0.002-0.29, p=0.004), and maternal two-hour plasma 
glucose during pregnancy (adjusted OR 2.06, 95% CI 1.14-3.74, p=0.02). 
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5.1 Sub-study results compared to existing literature in South Africa and globally 
5.1.1 Anthropometric characteristics 
A comparison of anthropometric findings from the sub-study with data from other South African 
studies in the available published literature is not meaningful. First, anthropometric findings 
amongst children in the South African National Health and Nutrition Examination Survey 
(SANHANES-1) (Shisana et al., 2014) reflected an age group older (6 to 9 years) than the 
participants in the sub-study (5 to 6 years) and therefore expected higher values than those for 
the sub-study. Second, South African and international reviewed studies in Chapter Two did 
not report anthropometric measurements of children’s calculated BMI expressed as a Z-score 
or centile but instead reported overweight and obesity proportions. Nevertheless, comparative 
data within the 2012 SANHANES-1 report (Shisana et al., 2014) between national and Western 
Cape anthropometric measurements are interesting albeit for a larger sample: the national 
mean weight for 6 to 9 year old boys (n=625/2123) was 24.4 kg (95% CI 23.9-24.9) and the 
mean height was 123.2 cm (95% CI 122.3-124.0) while data for this group for the Western 
Cape (n=318) at the time, this was 23.7 kg and 113.6 cm respectively. This can be interpreted 
to mean that boys in the Western Cape had a comparable weight but were shorter in stature 
than the national mean. For girls in the Western Cape (n=300), the mean weight was 25.6 kg 
(national mean 25.4 kg, 95% CI 24.6-26.3, n=2155) and the mean height was 116.5 cm 
(national mean 123.9 cm, 95%CI 122.8-125.0). This can be interpreted to mean that girls in 
the Western Cape had a comparable weight but were shorter in stature than the national mean. 
An analysis of data by race of 6 to 9 year-olds in the SANHANES-1 survey (Shisana et al., 
2014) shows a national mean weight of 24.7 kg for Black boys (n=1629) and 23.7 kg for 
Coloured boys (n=433) and a mean height of 117.4 cm for Black boys and 116.1 cm for 
Coloured boys. In this survey, the overall mean weight for Black boys in the Western Cape was 
marginally higher (.3 kg) than the national average (24.4 kg) but Coloured boys weighed 
marginally less (.7) than the national average. Both the Black and Coloured boys were shorter 
than the national average (123.2 cm). The mean weight for Black and Coloured girls was similar 
(27.0 kg and 27.4 kg respectively) and above the national mean of 25.4 kg but their mean 
height (118.5 cm for Black girls; 120.6 cm for Coloured girls) was lower than the national mean 
height of 123.9 cm. 
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Despite the higher age group in the national survey, the median BMI score in the present sub-
study (15.7 kg/m2, IQR 14.5-17.3) was not very different from the overall BMI for the group of 
6 to 9 year-old children (Shisana et al., 2014) of 15.9 kg/m2 (95% CI 15.7–16.1). In the national 
survey, the overall BMI in the Western Cape was 17.3 kg/m2 (95% CI 16.7–17.9) and higher 
than the national median BMI. Median Z-scores for height, weight and BMI are not reported in 
the national survey and can therefore not be compared with data from the sub-study. 
5.1.2 The proportion of fetal macrosomia in GDM exposed pregnancies in the years 
2010 and 2011 at Groote Schuur Hospital (GSH) 
The overall prevalence of fetal macrosomia in infants at birth (>4000 gm) exposed to GDM 
during the pregnancy was 12.3% (8/76, 10.5% among boys; 13/95, 13.7% for girls) (Table 4.4). 
GDM has been linked to overweight at birth in exposed infants. Infants who had been exposed 
to an intrauterine environment of either high blood sugar levels during uncontrolled diabetes or 
maternal obesity were LGA, with a birth weight above the 90th percentile (Boney et al., 2005; 
Najafian & Cheraghi, 2012). In an Iranian cohort study on macrosomia diabetic participants 
delivered 39.5% macrosomic babies compared to 6.1% in the control-group (P<0.05) (Najafian 
& Cheraghi, 2012) (Table 2.2).   
5.1.3 Prevalence of overweight and obesity in 5 and 6-year-old children  
In the sub-study, overweight and obesity were calculated using Z-scores (standard deviation 
scores). In the Z-score system, the anthropometric value is expressed as a number of standard 
deviations (SDs) below or above the reference mean or median value WHO, 1997). According 
to the WHO (1997), “For population-based uses, a major advantage is that a group of Z-scores 
can be subjected to summary statistics such as the mean and standard deviation” (p.1). Z-
scores are gender-independent, so children’s growth status can be determined by combining 
gender and age groups (WHO, 1997). Few prevalence studies discussed in this sub-section 
reported using Z-scores, making a comparison of data in the sub-study to the published 
literature difficult. 
In a 2012 SANHANES-1 study, the combined prevalence of overweight and obesity in South 
African 6 to 14 year old children is reported as 16.7% for Black African boys and 23.5% for 
Black African girls and for Coloured boys and girls this was lower at 11.8% and 19.9% 
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respectively. When compared to the earlier 2006 Health of the Nation study conducted by 
Armstrong et al. of 6 to 13 year olds, the combined overweight and obesity for Black African 
boys and girls was 9.7% and 17.0% respectively, and for Coloured boys and girls the combined 
overweight and obesity was 11.7% and 15.5% respectively (SANHANES-1, 2012). As can be 
seen from these two studies, there is a rising trend in the prevalence of overweight and obesity 
among South African children. Our study showed that for 5 to 6 year old GDM exposed children 
there was a combined prevalence of overweight and obesity of 27.6% (Table 4.4). This is nearly 
double that reported in other South African studies of children of different age groups. Results 
of the sub-study imply a tendency towards overweight and obesity in children in the Western 
Cape when exposed to GDM during pregnancy. 
According to the National Center for Health Statistics (NCHS) (2016), during the early 1970s, 
the overweight rate for USA children aged 2 to 19 years, was 10.2% and the obesity rate for 
the same group was 5.2%. In 2014 the overweight and obesity rates for the same cohort 
escalated to 16.2% and 17.2% respectively (NCHS, 2016). Despite representing a lower age 
group, using BMI Z-scores, the prevalence of overweight in the cohort of 5 and 6 year old 
children in our sub-study was 13.4% and the prevalence of obesity was 14.1%, pointing to a 
similar trend to the NCHS findings. 
5.1.4 Consequences of childhood overweight and obesity 
Overweight and obesity are the main cause of psychological problems and low self-esteem 
during childhood (Rossouw et al., 2012; WHO, 2015; WHO, 2016). Low self-esteem, 
depression and social isolation caused by overweight and obesity in children can decrease 
confidence to participate in physical activities. Overweight and obesity are key factors that 
contribute to poor physical health. Obesity may lead to insulin-resistant metabolic conditions in 
affected children as they get older (Ge et al., 2014; Gebremedhin, 2015).  
Overweight and obesity are key factors that not only contribute to poor health but also make 
more demands on health systems, particularly in low to medium-income countries, such as 
South Africa. Although overweight and obesity in children are on the rise worldwide, this is 
more so in low and- middle-income countries (WHO, 2016). A 6.8% prevalence of overweight 
and obesity in children has become a public health problem in Sub-Saharan Africa 
(Gebremedhin, 2015). The tendency to overweight and obesity is not isolated to one group or 
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even to a few countries and has consequently become a global health problem that is a burden 
on government resources and their health care systems. 
5.1.5 Risk factors (child and maternal) associated with increased risk for overweight 
in 5 and 6-year old children exposed to GDM during pregnancy 
Overall, 37/134 (27.6%) children were classified as either overweight or obese at ages 5 to 6 
years (Table 4.4). Variables that had a statistically significant association with overweight and 
obesity in the 5 and 6-year old children exposed to GDM were: age in years, the number of 
adults in the house, birth weight, and maternal two-hour plasma glucose during pregnancy. A 
potential risk factor was maternal fasting plasma glucose during pregnancy where the P-value 
approached significance. Data from the sub-study did not identify ethnicity as a risk factor 
associated with overweight and obesity in children exposed to GDM during pregnancy even 
though data were skewed in favour of the Coloured participants (80.7%). 
The 2012 SANHANES-1 national survey (Shisana, 2014) reported a prevalence of overweight 
(16.5%) and obesity (7.1%) among South African girls to be significantly higher than in boys 
(overweight 11.5%; obesity 4.7%). Girls in the Western Cape had a higher rate (7.2%) of 
obesity than girls living in the Northern Cape who had an obesity rate of 3.5%.  
Univariate analysis of data from the sub-study (Table 4.5) showed that there was a statistically 
significant difference (P=0.03) between mothers of 5 to 6-year old children of normal weight 
and those who were overweight or obese if they had completed at least 12 years of schooling 
(grade 12/matric) and may have completed tertiary level education. However, multivariate 
analysis of this sub-study data did not identify maternal education as a risk factor associated 
with overweight or obesity in 5 to 6-year old children. This contrasts with a South African study 
reporting low maternal education and a sedentary lifestyle as associated risk factors 
contributing to overweight and obesity in children aged 1 to 9 years (Kruger et al., 2006).  
The number of adults in the house was included as part of a number of socio-economic status 
(SES) variables. SES is a complex measure and cannot be derived from this variable alone. It 
is very likely that this association is confounded by other (measured and unmeasured) SES 
variables and requires further investigation. Most of the reviewed studies (Table 2.2), that 
reported an increase in childhood overweight, indicated a 10-11% difference between 
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overweight in offspring of GDM mothers and those of non-GDM mothers with pre-existing or 
maternal overweight as an associated risk factor.  
5.2 Critique of the sub-study 
5.2.1 Strengths and limitations of the sub-study methods 
5.2.1.1 Strengths of the record review process 
The sub-study was undertaken in a government sector hospital because in private healthcare 
settings there may not be standardized and supervised protocols to ensure early screening, 
diagnosis and treatment to identify GDM and reduce the potential risk of overweight and obesity 
in childhood. Patient characteristics and outcomes are captured in medical records. For the 
retrospective review by one reviewer, explicit review criteria were used rather than implicit 
criteria that made the data collection process more objective and reliable. Start and cutoff dates 
for the period under review made data collection easier. An expert was available for assistance 
with interpretation of the data when needed. The layout of the data collection review form 
facilitated data recording, coding, extraction and analysis with speed and accuracy under field 
conditions (Kyriacos, 2011).  
5.2.1.2 Limitations of record review 
The mothers were contacted telephonically to obtain data not found on the record review form 
of their children. The additional data were then immediately recorded on the data collection 
document in an Excel Spreadsheet. This data might have been unreliable due to the mother’s 
inability to accurately recall information. The manual process of data extraction from 
handwritten medical records slowed the process of data collection and might have been 
expedited if an electronic database was available. Information was not always legible or 
complete.  
5.2.2 Limitations and strengths of the sub-study 
Limitations of the sub-study include not reporting the validation results for pilot testing of the 
questionnaire for the larger study nor for the sections in the questionnaire from already 
validated measuring tools. Constraints imposed by the school system and working conditions 
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of mothers prevented all the mothers included in the larger study from bringing their children 
for measurement of height and weight and this limited recruitment to the sub-study. The 
absence of a control group may have influenced the results of this sub-study. Single readings 
for anthropometry were used instead of a mean of three as this was not a major objective of 
the parent study. 
Birth length and head circumference were missing from most of the children’s records. Practice 
guidelines stipulate that birth length and head circumference must be measured and recorded 
at birth, however, in practice these measurements may not have been measured and recorded 
by the midwives. This limited interpretation of the data. Missing data were reported but not 
addressed. The low numbers in some categories (when considering ethnicity) and the known 
location of the study might risk identification of individuals. 
5.2.3 Generalisability of study results 
This appears to be the first study to report the prevalence of overweight and obesity in children 
born from GDM complicated pregnancies in sub-Saharan Africa. The limited scope of the sub-
study is appropriate for a minor dissertation. This was therefore not a national but a regional 
study. Study results therefore, are generalisable only to children exposed to GDM in the 
Western Cape of South Africa but may not be generalized to children in other regions in the 
country due to population differences. Even so, data were taken from a limited population of 
mostly Coloured and Black and residents from the Western Cape, South Africa.  
5.3 Conclusions and recommendations 
5.3.1 Conclusions 
At birth, the overall prevalence of macrosomia found in this sub-study is considered high but 
cannot be interpreted meaningfully because there are limited published data from South African 
studies on fetal macrosomia in GDM exposed infants. The combined prevalence of overweight 
and obesity in 5 to 6-year old children who were exposed to GDM is higher than that in children 
who had not been exposed to GDM in utero as reported in other South African studies. This 
implies a tendency towards overweight and obesity in children in the Western Cape region 
although the data show no statistical significance. Risk factors for overweight and obesity in 5 
and 6-year old children exposed to GDM were found to be birth weight, age in years and 
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maternal two-hour plasma glucose during pregnancy and a potential risk factor was maternal 
fasting plasma glucose during pregnancy. 
5.3.2 Recommendations 
5.3.2.1 Recommendations for nursing and midwifery education and practice 
Evidence based health education should be provided for pregnant women, in addition to a 
whole person-centred approach to achieve a healthy lifestyle. Prevention of GDM should be 
emphasised. Educational content should include risk factors associated with the development 
of GDM. If GDM is present in pregnancy, education should also include management thereof.  
Current guidelines for screening need to be implemented. Early and comprehensive screening 
methods and techniques need to be implemented and conducted throughout the pregnancy. 
GDM diagnosed mothers must be monitored regularly to prevent the unborn child from 
exposure to high blood sugar levels. Curricula for nursing and midwifery programmes should 
reflect the content as outlined above. 
5.3.2.2 Recommendations for policy and healthcare services 
It is imperative that increasing maternal overweight and obesity, a modern public health 
challenge, should be tackled aggressively. Early intervention in the life of a child can have a 
significant impact on the prevention of childhood overweight and obesity (Desai et al., 2012). 
Childhood obesity is a strong predictor of adult obesity. In an effort to curb adult obesity, it is 
essential not only to conduct early screening in children to prevent adulthood overweight or 
obesity (van der Merwe, 2012) but then when found, to follow-up and monitor these children. 
It is recommended that resources should be allocated for large campaigns to ensure maternal 
and infant health which will require effective and innovative leadership such as the Western 
Cape Department of Health’s First 1000 Days campaign (Western Cape Government, 2017). 
It is vital that this public health challenge of increasing maternal overweight and obesity be 
acted on as soon as possible to prevent an epidemic of health problems and risk factors 
associated with overweight and obesity in the near future. It is recommended that aggressive 
leadership and effective measures be taken to prevent this epidemic from getting out of control. 
A first step would be to adhere to the United Nations (UN) Sustainable Development Goals, 
specifically goal number three – good health and welfare where the goal is to ensure healthy 
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lives and promote well-being for all at all ages (United Nations Development Programme 
(UNDP), 2016). By adopting this sustainable development goal the health risks to mother and 
child can be significantly lowered and some risks may be eliminated.  
Although the UN’s target goals are long-term in nature, it is vital for all healthcare personnel to 
be focused and aggressively pursue these goals to prevent children from falling victim to the 
problem of overweight and obesity. It is recommended that intervention-based research should 
be conducted in South African schools and other places where large groups of people gather 
such as churches. Adherence to the Strategic Plan for Prevention and Control of Non-
Communicable Diseases 2013-2017 from The South African National Department of Health 
will also assist in the prevention and control of childhood overweight and obesity. 
5.3.2.3 Recommendations for further research 
The cycle of childhood overweight and obesity that originates from mothers with GDM 
associated pregnancies, maternal overweight and obesity, and other related health risk 
factors in South Africa needs to be investigated. This problem has not been researched 
adequately to protect future generations of children from overweight and obesity and the 
long-term effects on their health. A larger, more diverse and inclusive study covering all 
socio-economic classes, provinces and childhood ages across South Africa is needed. 
Mothers attending both private and public healthcare facilities need to be included in future 
studies to improve the diversity among social classes of the South African population.  
Regional data is useful, but it is recommended that more South African studies should be 
conducted on risk factors associated with overweight and obesity in children using larger 
sample sizes in all provinces and across all socio-economic boundaries. Qualitative research 
methods should be undertaken to understand perceptions and behavioural patterns. Well 
designed studies and valid data are needed to develop evidence-based policies for the 
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Appendix A: Questionnaire used in the parent study 
 
MOTHER PERSONAL INFORMATION 
1 First name  
2 Middle name  
3 Last name  
4 Home address   
5 District  
6 Home phone  
7 Mobile phone  
8 Email address  
9 Mother birthday  MM_______/DD__________ /YYYY________ 
Demographics 
10 Place of birth  □ Western Cape              □ Cape Town     
□ Inside South Africa       □ Outside South Africa 
11 Resides (location) □ Urban                   □ Non-Urban 
12 Age Current Age   _______                                 
Maternal Age ________ 
13 Number of adults in household □ One   □ Two   □ Three   □ Four   □ More than Four 
14 Marital Status: □ Married / Domestic Partner  
□ Divorced       
□ Widowed      





15  Number of children in  
 household: 
□ One   □ Two   □ Three   □ Four   □ More than Four 
16 Highest Education completed □ Less than Secondary Schooling   
□ Graduated Secondary Schooling   
□ Some Post-Secondary Schooling   
□ Completed Post-Secondary Schooling 
17 Do you own a house □ Yes                        □ No 
17a Type of house you live in  □ building                 □ shack/informal structure 
17b Toilet in house  □ Yes                        □ No 
17c Shared tap-water with other 
households? 
□ Yes                        □ No 
18 Electricity in house  □ Yes                        □ No 
19 Household Income: □ Low  
□ Middle  
□ High 
20 Ethnic Origin (Check One) □ Black  □Colored  □ White  □ Indian  □ Other 
21 South African Citizenship □ Yes                        □ No 
22 Employment status: □ Employed  
□ Self-employed 
□ Unemployed 
□ A homemaker 
□ A student 
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23 How would you say your 
health is, in general  
□ Excellent 




24 Family history  □ Diabetes  
□ T2DM    
□ High Blood    
□ Heart disease  
□ Cancer 
□ Other 
25  Do you take tablets for 
diabetes?  
 Do you get insulin 
injections?  
 
□ Yes           □ No           
                       
□ Yes          □ No  
26 Have you ever been 
hospitalized for GDM or 
diabetes? 
□ Yes          □ No           
 
27 Did you breastfeed this child? □ Yes           □ No           
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28 Has your general health 
changed in the past year?  
□ YES  
□ NO  
□ Not Sure 
If yes, please explain. __________________________ 
29 Last medical examination □ Last 6 months  □  Last year   □  Last two years 
30 a. At what gestational 
age were you 
diagnosed with 
diabetes 
b. Results of Fasting 
blood sugar? 
 
c.  Results of two-hour 
blood sugar? 
 
d. How was the diabetes 
managed? 
□ Before 20weeks pregnancy 
□ between 28 and 32weeks pregnancy 
□ between 36 and 40weeks pregnancy 
 
 
□ normal     □ abnormal 
 
 




□ Oral medication 
□ Insulin 
□ Combination of diet and other 
31 Perception of own weight □ Underweight   
□ Normal Weight  
□ Overweight/Obese 
32 Weight Before pregnancy (kg) _______   
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Current Weight (kg) ________ 
33 Height ________cm   
34 BMI at booking  




36  Do you smoke: 
 
□ Non-Smoker 
□ Current Smoker 
□ Smoke When Pregnancy 
37 HIV status positive  □ Yes         □ No         □ Unknown 
38  Do you drink alcohol: 
 
□ Non-Drinker 
□ Current Drinker 
□ During Pregnancy 
39 Rate your physical activity □ More active      
□ Less active     
□ Same as other (Specify) ________________ 
CHILD DATA COLLECTION 
40 First name  
41 Middle name  
42  Last name  
43  Gender □  Male          □ Female         
44  Age □ 5-year old                 □ 6-year old 
45 Ethnic Origin (Check One) □ Black   □ Colored   □White  
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□ Indian  □  Mixed     □Other 
46 Type of birth/delivery □ Vaginal            □ Caesarean 
47 Any complications during birth □ Yes  
□ No 





Current Weight (kg) ______ 
Current Height (kg)  _______ 
49 Body Mass Index kg/m2: 
 
□ Underweight (kg) ___ 
□ Normal Weight (kg) ___ 
□ Overweight (kg) ___ 
□ Obese (kg) ___ 
50 Previous Hospitalizations 
 
□ Yes  
□ No 
If Yes, please give reason ___________________ 
This form will gather data on overweight and obesity in 5 to 6-year old children exposed to 
GDM during pregnancy. This questionnaire will be used to gather personal data on Cape Town 
5- and 6-year-old children including necessary information to determine their BMI. Anonymized 
data will be used by stakeholders, selected organizations, and governmental institutions to 
design new programs and services that will help prevent future overweight/obesity in children. 
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Confidentiality: The confidentiality of mother, child and family information is of great concern 
to the researchers assigned to this study.  The research team and assistants promise to comply 
with all university and state data protection legislation and medical confidentiality guidelines.  
Medical information: All medical information will be kept confidential. No information will be 
disclosed to anyone not involved in the study and without the participant approval. 
Research:  Anonymized or aggregated data may be used for research or statistical purposes.  
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Appendix B: Data extraction form for sub-study 
 
Child Questionnaire 
Study ID: PRO2D                                                  Year of Study: 2016 
Date Form Completed:                
First Author:  Magret C Haynes  
Data Extractor: Magret C Haynes 
1. General Information  
Participant’s Case Number:  
Country of Study:  South Africa 
Study Funding Source or Type:  UCTFHS 
Potential Conflict of Interest from Funding?  
Yes      No    (If No Exclude)  Unclear   
2. Study Eligibility 
2a.  Study Characteristics  
2b.  Type of study Cross Sectional Study 
2c.  Does the Study Design Meet the Criteria 
for Inclusion? 
Yes           No    (If No Exclude)  Unclear   
3. Study Participants 
3a.  Description of Participants 5 to 6-year old children exposed to Gestational 
Diabetes in utero. 
3b.  Are participants defined as a group 
having specific social or cultural 
characteristics? 
Yes           No         Unclear    (Specify in detail) 
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3c.  How is the geographic boundary 
defined? 
Specify Details: The study population includes only 
children born in 2010-2011 at Groote Schuur Hospital 
in Western Cape, South Africa 
3d.  Do the participants meet the criteria for 
inclusion? 
Yes           No    (If No Exclude) 
4. Study Intervention 
4a.  Intervention Type?  
4b.  Intervention Strategy? History taken from Mother regarding age of child, type 
of delivery, birth weight, any hospitalizations of the 
child involved etc. The anthropologic measurements of 
child will be taken if child and mother agreed to. 
Measurements: weight and height will be documented 
to calculate BMI. 
4c.  Focus of the intervention Association of overweight 
4d.  Does the intervention meet the criteria 
for inclusion? 
Yes           No    (If No Exclude) Unclear     
4e.  Duration of intervention (Specify 
Period)   
June 2016 to December 2016 
4f.  Is the duration of intervention adequate 
for inclusion? 
Do the outcome measures meet the criteria for 
inclusion? 
5.  Study Outcomes 
5a.  Identify Outcomes Overweight       Obesity     List other risk factors   
5b.  Do the outcome measures meet the 
criteria for inclusion? 






























Low (less than 2500g) 
___ 
Normal (2500-3999g) ___ 
Macrosomia (Greater 




Current Weight (kg) 
____ 
Current Height (kg) 
____ 
 










Underweight (kg) ___ 
Normal Weight (kg) 
___ 
Overweight (kg) ___ 


















If Yes, please give 
reason for admission. 
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Appendix E:  Anthropometry Graphics 
 
 























Figure 4. 2: Children ‘s head circumference at birth, in centimeters 
 
 




































Figure 4. 4: Children’s weight at 5 and 6 years of age, in kilograms 
 


































Appendix F:  JHNEBP Evidence Rating Scales 
 
 STRENGTH of the Evidence  
Level I    Experimental study/randomized controlled trial (RCT) or meta-analysis of RCT 
Level II  Quasi-experimental study 
Level III  Non-experimental study, qualitative study, or meta-synthesis. 
Level IV  Opinion of nationally recognized experts based on research evidence or expert 
consensus panel (systematic review, clinical practice guidelines) 
Level V  Opinion of individual expert based on non-research evidence. (Includes case studies; 
literature review; organizational experience e.g., quality improvement and financial 
data; clinical expertise, or  personal experience)  
 
QUALITY of the Evidence  
A   High    
  
Research  Consistent results with sufficient sample size, adequate 
control, and definitive conclusions; consistent 
recommendations based on extensive literature review that 
includes thoughtful reference to scientific evidence.  
Summative 
reviews   
Well-defined, reproducible search strategies; consistent 
results with sufficient numbers of well-defined studies; 
criteria-based evaluation of overall scientific strength and 
quality of included studies; definitive conclusions.  
Organizational  well-defined methods using a rigorous approach; consistent 
results with sufficient sample size; use of reliable and valid 
measures  
Expert Opinion  expertise is clearly evident  
B   Good  Research  reasonably consistent results, sufficient sample size, some 
control, with fairly definitive conclusions; reasonably 
consistent recommendations based on fairly comprehensive 
literature review that includes some reference to scientific 
evidence  
Summative 
reviews   
Reasonably thorough and appropriate search; reasonably 
consistent results with sufficient numbers of well-defined 
studies; evaluation of strengths and limitations of included 
studies; fairly definitive conclusions.  
Organizational  Well-defined methods; reasonably consistent results with 
sufficient numbers; use of reliable and valid measures; 
reasonably consistent recommendations  
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Expert Opinion  expertise appears to be credible.  




Research  little evidence with inconsistent results, insufficient sample 
size, conclusions cannot be drawn  
Summative 
reviews   
undefined, poorly defined, or limited search strategies; 
insufficient evidence with inconsistent results; conclusions 
cannot be drawn  
Organizational  Undefined, or poorly defined methods; insufficient sample 
size; inconsistent results; undefined, poorly defined or 
measures that lack adequate reliability or validity  
Expert Opinion  expertise is not discernable or is dubious.  
 
*A study rated an A would be of high quality, whereas, a study rated a C would have major 
flaws that raise serious questions about the believability of the findings and should be 
automatically eliminated from consideration. Newhouse R, Dearholt S, Poe S, Pugh LC, White 
K. The Johns Hopkins Nursing Evidence-based Practice Rating Scale.  2005. Baltimore, MD, 
The Johns Hopkins Hospital; Johns Hopkins University School of Nursing.©  The Johns 




Appendix G:   STROBE Guideline for reporting observational studies  
STROBE Guideline for reporting observational studies 
 
Item Item  
No 




1 (a) Indicate the study’s design with a 
commonly used term in the title or the 
abstract  
Title on cover page, Abstract 
pg.v 
(b) Provide in the abstract an informative 
and balanced summary of what was done 
and what was found 




2 Explain the scientific background and 
rationale for the investigation being 
reported  
Chapter 1: Section 1.1 pg 1 
Section 1.4, pg 3 
Chapter 2, Introduction and 
themes extracted from a 
review of the published 
literature pg. 5-10 
Objectives 3 State specific objectives, including any 
pre-specified hypotheses  
1.4.2 Objectives, pg. 3 
Methods 
Study design 4 Present key elements of study design 
early in the paper 
In Abstract, pg. v 
Chapter 3, Section 3.3 pg. 28 
Setting 5 Describe the setting, locations, and 
relevant dates, including periods of 
recruitment, exposure, follow-up, and 
data collection 
Chapter 3, Section 3.1 & 3.2.1 
pg. 27 
Section 3.4, pg.29 
Fig 3.1 pg. 30 
Section 3.7, pg. 32-35 
Participants 6 (a) Cross-sectional study—Give the 
eligibility criteria, and the sources and 
methods of selection of participants 
Section 3.5, 3.6, pg. 29, 31 
(b) Cohort study—For matched studies, 
give matching criteria and number of 
exposed and unexposed 
Case-control study—For matched 
studies, give matching criteria and the 







Clearly define all outcomes, exposures, 
predictors, potential confounders, and 
effect modifiers. Give diagnostic criteria, if 
applicable 
Section 3.2, pg.27-28 
Potential confounders and 




8*  For each variable of interest, give 
sources of data and details of methods of 
Section 3.2.1, pg. 27-28 
Section 3.8.2, pg.36-37 
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Item Item  
No 
Recommendation Application to study 
Section, Page 
assessment (measurement). Describe 
comparability of assessment methods if 
there is more than one group 
Bias 9 Describe any efforts to address potential 
sources of bias 
Section 3.6, pg. 29 
Study size 10 Explain how the study size was arrived at Section 3.6, pg. 29-31 
Quantitative 
variables 
11 Explain how quantitative variables were 
handled in the analyses. If applicable, 
describe which groupings were chosen 
and why 
Grouping was by gender. 
Section 3.2.1 pg. 27-28 
Section 3.2.2 pg. 28 
Section 3.7.2 pg. 32-33 
Section 3.7.4.2 pg. 34-35 
Statistical 
methods 
12 (a) Describe all statistical methods, 
including those used to control for 
confounding  
Section 3.8 (3.8.1, 3.8.2) pg. 
36-37 
(b) Describe any methods used to 
examine subgroups and interactions 
Section 3.8.2, pg.36 
(c) Explain how missing data were 
addressed  
Missing data were reported 
but not addressed  
Section 3.7.4.1 p.33 
Section 4.1 pg. 43 
(d) Cohort study—If applicable, explain 
how loss to follow-up was addressed  
Case-control study—If applicable, explain 
how matching of cases and controls was 
addressed  
Cross-sectional study—If applicable, 
describe analytical methods taking 







(e) Describe any sensitivity analyses Not applicable 
Results 
Participants 13* (a) Report numbers of individuals at each 
stage of study e.g. numbers potentially 
eligible, examined for eligibility, confirmed 
eligible, included in the study, completing 
follow-up, and analyzed 
Section 3.6, Flow diagram 3.1, 
pg. 30 
  (b) Give reasons for non-participation at 
each stage 
Flow diagram 3.1, pg. 30 
(c) Consider use of a flow diagram Pg. 30 
Descriptive data 14* (a) Give characteristics of study 
participants (e.g. demographic, clinical, 
social) and information on exposures and 
potential confounders 
Tables 4.1-4.5, pg. 40-49 
(b) Indicate number of participants with 




Item Item  
No 
Recommendation Application to study 
Section, Page 
(c) Cohort study—Summarise follow-up 
time (e.g., average and total amount) 
Not applicable 
Outcome data 15* Cohort study—Report numbers of 
outcome events or summary measures 
over time 
Not applicable 
Case-control study—Report numbers in 
each exposure category, or summary 
measures of exposure 
Not applicable 
Cross-sectional study—Report numbers 
of outcome events or summary measures 
Tables 4.1-4.5, pg. 40-49 
Main results 16 (a) Give unadjusted estimates and, if 
applicable, confounder-adjusted 
estimates and their precision (eg, 95% 
confidence interval). Make clear which 
confounders were adjusted for and why 
they were included 
Multivariate analysis 
Table 4.5, pg. 47-49  
  (b) Report category boundaries when 
continuous variables were categorized 
(c) If relevant, consider translating 
estimates of relative risk into absolute risk 
for a meaningful time period 
Not applicable 
Other analyses 17 Report other analyses done eg analyses 




Key results 18 Summarise key results with reference to 
study objectives 
Section 5.0, pg. 51 
Limitations 19 Discuss limitations of the study, taking 
into account sources of potential bias or 
imprecision. Discuss both direction and 
magnitude of any potential bias 
Sections 5.2.1–5.2.2 pg. 56-57 
Interpretation 20 Give a cautious overall interpretation of 
results considering objectives, limitations, 
multiplicity of analyses, results from 
similar studies, and other relevant 
evidence 
 
Sections 5.1.1 – 5.1.5 pg. 52-
55 
Generalisability 21 Discuss the generalizability (external 
validity) of the study results 
Section 5.2.3, pg. 57 
 
Funding 22 Give the source of funding and the role of 
the funders for the present study and, if 
applicable, for the original study on which 
the present article is based 





*Give information separately for cases and controls in case-control studies and, if applicable, for 
exposed and unexposed groups in cohort and cross-sectional studies. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives 
methodological background and published examples of transparent reporting. The STROBE 
checklist is best used in conjunction with this article (freely available on the Web sites of PLoS 
Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, 




   





















Appendix I:  Consent for child participation 
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